JP7024841B2 - Drug distribution support system - Google Patents

Description

The present invention relates to a drug distribution support system for supporting drug distribution work.

In recent years, packaged containers such as drug packages that package drugs according to the time of administration are collectively stored in a delivery container such as a drug bag for each of multiple users belonging to a predetermined drug distribution group, and the delivery container is stored. It may be desirable to deliver to a delivery destination such as the Long-Term Care Health Facility (hereinafter referred to as "Long-Term Care Health Facility"). According to such an operation, at the delivery destination, it becomes possible to take out the packaging containers of a plurality of users belonging to the same drug distribution group from the delivery container at each time of administration and easily administer the drug to each user. .. Here, when accommodating a plurality of packaging containers in a delivery container, it is necessary to strictly check that the correspondence between the packaging container and the delivery container is correct. As a prior art, there is known a technique of printing a drug bag identification information on a drug package and a drug bag to prevent an error in inserting the drug package into the drug bag (see Patent Document 1).

Japanese Unexamined Patent Publication No. 2000-24807

However, in the above-mentioned conventional technique, since the implementation of the drug distribution work in which the drug packages of a plurality of users are collectively stored in the drug bag at each time of administration and delivered to the delivery destination is not considered, the drug package and the drug bag are used. The information printed on both does not include delivery address and dosing time information.

An object of the present invention is a drug distribution support system capable of suppressing human error in a drug distribution operation in which packaged containers of a plurality of users are collectively stored in a delivery container at each time of administration and delivered to a delivery destination. Is to provide.

The drug distribution support system according to one aspect of the present invention includes a first recording means, a second recording means, and a determination means. The first recording means is placed in a packaging container used for packaging a drug to be taken by one user at each administration time or in a first recording medium attached to the packaging container at the time of administration and in advance. Record the first drug distribution information including the specified delivery destination identification information. The second recording means is a delivery container used for accommodating the packaged containers of a plurality of users belonging to a predetermined drug distribution group at the same dosing time, or a second record attached to the delivery container. The medium contains the second drug distribution information including the time of administration and the predetermined delivery destination identification information. The determination means is the administration time of the first drug distribution information read from the packaging container or the first recording medium, the delivery destination identification information, and the second delivery container or the second recording medium read from the delivery container or the second recording medium. It is determined whether or not the dosing time of the drug distribution information and the delivery destination identification information match.

According to the present invention, since it is determined whether or not the dosing time and the delivery destination of the sachet and the delivery container match, the sachets of a plurality of users are collectively stored in the delivery container for each dosing time. It becomes possible to suppress human error in the drug distribution work of delivering to the delivery destination.

More specifically, it is conceivable that the drug distribution support system further includes a notification means for notifying the determination result of the determination means. As a result, the user can recognize the determination result of the determination means.

Further, in the determination means, the first drug distribution information is obtained from all the packaging containers predetermined as the packaging containers housed in the same delivery container or the first recording medium of the packaging container. It is conceivable to determine whether or not it has been read. This makes it possible to suppress the leakage of the packaged container into the delivery container.

Further, the determination means is the first from all the delivery containers predetermined as the delivery containers to be simultaneously delivered to the delivery destinations corresponding to the same delivery destination identification information, or the second recording medium of the delivery containers. 2 It is also conceivable to further determine whether or not the drug distribution information has been read. This makes it possible to suppress delivery omission of the delivery container to the delivery destination corresponding to the same delivery destination identification information.

Further, it is conceivable that the first drug distribution information includes the user identification information of the user. In this case, the drug distribution support system is a storage means for storing a face image of each user corresponding to the user identification information, and when the first drug distribution information is read from the packaging container. It is conceivable to further include a display control means for reading out and displaying the face image of the user corresponding to the user identification information of the first drug distribution information from the storage means. As a result, when the packaged container is provided to the user, the face image of the user corresponding to the packaged container can be confirmed, and it becomes possible to suppress a medication error.

By the way, whether or not the drug distribution support system matches the delivery destination identification information of the second drug distribution information read from the delivery container at the delivery destination with the delivery destination identification information corresponding to the delivery destination. It is also conceivable to further provide a delivery destination determination means for determining. This makes it possible to suppress erroneous delivery of the delivery container to the delivery destination.

Further, based on the prescription data used when the drug distribution support system packages the drug into the packaged container at each time of administration, the information on the time of taking the drug packaged in the packaged container and the person who takes the drug. It is provided at a pharmacy side terminal having a drug distribution data output means capable of outputting drug distribution data including, and a delivery destination to which a plurality of the packaging containers corresponding to a plurality of users are delivered, and is output from the pharmacy side terminal. It is conceivable to include a facility-side terminal having a drug distribution data input means capable of inputting the above-mentioned drug distribution data. As a result, at the delivery destination, the drug distribution data can be used for improving the efficiency of the drug distribution work and suppressing medication errors in the drug distribution work.

Further, in the drug distribution support system according to another aspect of the present invention, the drug packaged in the packaged container is based on the prescription data used when the drug is packaged in the packaged container at each time of administration. Provided at a pharmacy-side terminal having a drug distribution data output means capable of outputting drug distribution data including information on the time of administration and the user, and a delivery destination to which the plurality of packaged containers corresponding to a plurality of users are delivered. , A facility-side terminal having a drug distribution data input means capable of inputting the drug distribution data output from the pharmacy-side terminal. As a result, at the delivery destination, the drug distribution data can be used for improving the efficiency of the drug distribution work and suppressing medication errors in the drug distribution work.

Further, it is conceivable that the facility-side terminal further includes a prescription display means for displaying the relationship between each user and each time of administration based on the drug distribution data input by the drug distribution data input means. .. As a result, the person in charge of drug distribution can easily grasp the relationship between each of the recipients and each of the administration times, and the efficiency of the drug distribution work and the suppression of dosing mistakes in the drug distribution work can be achieved.

Specifically, the prescription display means includes a first display processing means for displaying a first display screen for selecting the dosing time based on the drug distribution data, and a selection of the dosing time on the first selection screen. It is conceivable to include a second display processing means for displaying a second display screen for displaying the necessity of distribution of each of the users at the time of administration. As a result, it is possible to easily identify the person who needs to distribute the medicine at each time of taking the medicine.

Further, it is also conceivable that the second display processing means can display the second display screen for each drug distribution group including a plurality of predetermined dosers. As a result, it is easier to confirm the necessity of drug distribution at each time of administration of the drug for each drug distribution group, as compared with the case where the information of all the users is displayed on one second display screen. can do.

Further, it is conceivable that the first display processing means displays the necessity of drug distribution for each of the administration times on the first display screen. As a result, the drug distribution worker can easily confirm the necessity of drug distribution at each time of administration, and the drug distribution work is streamlined.

On the other hand, it is conceivable that the second display processing means displays the medication status of the medication recipient in a preset display format. As a result, the drug distribution worker can easily grasp the medication status of the drug recipient, and the drug distribution work is streamlined.

Further, it is conceivable that the facility-side terminal further includes a medication completion input means for receiving a medication completion input operation for each user displayed on the second display screen. This makes it possible to easily confirm whether or not the medication has been completed for each user.

Further, it is conceivable that the facility-side terminal may further include a residual drug information output means capable of receiving the input operation of the residual drug information regarding the residual drug that the user did not take and outputting the residual drug information. Thereby, by referring to the remaining drug information, it is possible to easily grasp the presence or absence of the remaining drug for each user, and for example, consideration should be given so that the drug is not wasted when prescribing the next drug. It is possible.

For example, the pharmacy-side terminal can input the residual drug information output from the residual drug information output means, the residual drug information input means, the residual drug information input by the residual drug information input means, and the distribution. It is conceivable to further provide a residual drug notification means capable of notifying information on available residual drugs based on the drug data. As a result, by using the residual drug shown in the residual drug information, it becomes possible to suppress the waste of the drug in the next dispensing.

Further, it is conceivable that the pharmacy-side terminal can output the drug distribution data in units of a drug distribution group including a plurality of predetermined dosers. Further, it is conceivable that the pharmacy-side terminal can extract one or a plurality of preset items from the prescription data and output them as the drug distribution data. Thereby, it is possible to easily use only the necessary prescription data among the prescription data.

By the way, it is conceivable that the drug distribution data includes information on side effects of the drug. This makes it possible for the facility to which the drug is delivered to easily refer to the information regarding the side effect of the drug.

It is conceivable that the facility-side terminal further includes an alarm notification means for executing an alarm notification process for notifying at a preset alarm time for each of the administration times. As a result, omission of administration at each of the administration times is suppressed.

It is conceivable that the facility-side terminal further includes an alarm setting means for executing an alarm setting process for automatically setting the alarm time according to a predetermined alarm condition for each of the administration times. As a result, the alarm time is automatically set for each of the administration times, so that the time and effort for setting the alarm time is reduced.

According to the present invention, a drug distribution support system capable of suppressing human error in drug distribution work in which packaged containers of a plurality of users are collectively stored in a delivery container at each time of administration and delivered to a delivery destination. Is realized.

FIG. 1 is a block diagram showing a schematic configuration of a drug distribution support system according to an embodiment of the present invention. FIG. 2 is a diagram showing an example of drug distribution management information used in the drug distribution support system according to the embodiment of the present invention. FIG. 3 is a flowchart showing an example of a flow of drug distribution work executed at a pharmacy and a delivery destination where the drug distribution support system according to the embodiment of the present invention is installed. FIG. 4 is a schematic diagram showing an example of a flow of drug distribution work executed at a pharmacy and a delivery destination in which a drug distribution support system according to an embodiment of the present invention is installed. FIG. 5 is a flowchart showing an example of a procedure of prescription data issuance processing executed by the drug distribution support system according to the embodiment of the present invention. FIG. 6 is a diagram showing an example of packaged data generated by a prescription data issuing process executed by the drug distribution support system according to the embodiment of the present invention. FIG. 7 is a diagram showing another example of packaged data generated in the prescription data issuing process executed by the drug distribution support system according to the embodiment of the present invention. FIG. 8 is a flowchart showing an example of a procedure for drug packaging processing executed by the drug distribution support system according to the embodiment of the present invention. FIG. 9 is a diagram showing an example of a packaging result of a drug packaging process executed by the drug distribution support system according to the embodiment of the present invention. FIG. 10 is a flowchart showing an example of a procedure of the accommodation time matching process executed by the drug distribution support system according to the embodiment of the present invention. FIG. 11 is a flowchart showing an example of a procedure of the delivery time matching process executed by the drug distribution support system according to the embodiment of the present invention. FIG. 12 is a flowchart showing an example of a procedure for collation at the time of receipt executed by the drug distribution support system according to the embodiment of the present invention. FIG. 13 is a flowchart showing an example of the procedure of the drug distribution time matching process executed by the drug distribution support system according to the embodiment of the present invention. FIG. 14 is a block diagram showing a schematic configuration of a drug distribution support system according to another embodiment of the present invention. FIG. 15 is a diagram showing an example of a facility master and a resident master used in the drug distribution support system according to another embodiment of the present invention. FIG. 16 is a diagram showing an example of a facility registration screen used in the drug distribution support system according to another embodiment of the present invention. FIG. 17 is a diagram showing an example of a resident registration screen used in the drug distribution support system according to another embodiment of the present invention. FIG. 18 is a flowchart showing an example of a procedure of prescription data issuance processing executed by the drug distribution support system according to another embodiment of the present invention. FIG. 19 is a diagram showing an example of drug distribution data used in the drug distribution support system according to another embodiment of the present invention. FIG. 20 is a flowchart showing an example of a procedure of a drug distribution time matching process executed by the drug distribution support system according to another embodiment of the present invention. FIG. 21 is a diagram showing an example of an initial screen displayed by the drug distribution support system according to another embodiment of the present invention. FIG. 22 is a diagram showing an example of an initial screen displayed by the drug distribution support system according to another embodiment of the present invention. FIG. 23 is a diagram showing an example of a resident list screen displayed by the drug distribution support system according to another embodiment of the present invention. FIG. 24 is a diagram showing an example of a resident list screen displayed by the drug distribution support system according to another embodiment of the present invention. FIG. 25 is a diagram showing an example of a resident confirmation screen displayed by the drug distribution support system according to another embodiment of the present invention. FIG. 26 is a diagram showing an example of a drug-free input screen displayed by the drug distribution support system according to another embodiment of the present invention. FIG. 27 is a diagram showing an example of a schedule input screen displayed by the drug distribution support system according to another embodiment of the present invention. FIG. 28 is a diagram showing an example of a side effect information input screen displayed by the drug distribution support system according to another embodiment of the present invention. FIG. 29 is a diagram showing an example of a resident status screen displayed by the drug distribution support system according to another embodiment of the present invention. FIG. 30 is a diagram showing an example of a history screen displayed by the drug distribution support system according to another embodiment of the present invention. FIG. 31 is a diagram showing an example of a history screen displayed by the drug distribution support system according to another embodiment of the present invention. FIG. 32 is a diagram showing an example of a history screen displayed by the drug distribution support system according to another embodiment of the present invention. FIG. 33 is a diagram showing an example of a history screen displayed by the drug distribution support system according to another embodiment of the present invention. FIG. 34 is a diagram showing an example of a history screen displayed by the drug distribution support system according to another embodiment of the present invention. FIG. 35 is a diagram showing an example of a history screen displayed by the drug distribution support system according to another embodiment of the present invention. FIG. 36 is a diagram showing an example of a packaging result of a drug packaging process executed by the drug distribution support system according to another embodiment of the present invention.

[First Embodiment]
Hereinafter, embodiments of the present invention will be described with reference to the accompanying drawings for the purpose of understanding the present invention. It should be noted that the following embodiments are examples that embody the present invention and do not limit the technical scope of the present invention.

[Pharmaceutical distribution support system 10]
As shown in FIG. 1, the drug distribution support system 10 according to the embodiment of the present invention includes a dispensing support device 1, a reading terminal 2, a drug packaging device 3, a printer 4, a drug distribution support device 5, and a mobile terminal 6. And a reading terminal 7 and the like. The dispensing support device 1, the reading terminal 2, the drug packaging device 3, and the printer 4 are connected wirelessly or by wire via a network N1 so as to be communicable. Further, the drug distribution support device 5, the mobile terminal 6, and the reading terminal 7 are connected so as to be able to communicate wirelessly or by wire via the network N2. The network N1 and the network N2 are LAN, WAN, the Internet, an intranet, or the like.

The dispensing support device 1, the reading terminal 2, the medicine packaging device 3, and the printer 4 are arranged in a pharmacy A where medicines are dispensed. The dispensing support device 1 is an example of a terminal on the pharmacy side, but the location may be outside the pharmacy A as long as it can be connected to the network N1. On the other hand, the medicine distribution support device 5, the mobile terminal 6, and the reading terminal 7 are arranged at each of the LTCF B, which is the delivery destination of the medicines dispensed at the pharmacy A. The LTCF B is a facility in which a plurality of users who take the medicines dispensed at the pharmacy A live. The LTCF B is only an example of a predetermined drug distribution group, and for example, an area including the homes of a plurality of predetermined drug users or a delivery route is also an example of the drug distribution group. Further, the drug distribution support device 5 is an example of a facility-side terminal, but the location thereof is outside the LTCF B if it is connected to the network N2 and can be used in the LTCF B. May be good. Further, it is conceivable that the dispensing support device 1 also has the function of the drug distribution support device 5.

[Chemical packaging device 3]
The drug packaging device 3 is a dispensing device capable of packaging a drug in a drug package 81 (see FIG. 4) at each time of administration based on the prescription data input from the dispensing support device 1. For example, the drug packaging device 3 is a tablet packaging machine for packaging tablets or a powder packaging machine for packaging powder. Specifically, the tablet packaging machine has a plurality of drug cassettes containing a plurality of types of tablets, and the tablets are dispensed from the drug cassette according to the prescription data and packaged in the drug package 81 at each time of administration. Perform the action. In addition, the powder packaging machine executes a packaging operation of packaging the charged powder with the drug package 81 at each time of administration according to the prescription data. The drug package 81 used for these packaging operations is an example of a packaging container. Further, it is also conceivable that the tablet packaging machine or the powder packaging machine can package the tablets and the powder into one package at each time of administration. In the drug packaging device 3, the drug package 81 is formed by heating and melting a part of a continuous long drug package sheet provided in the drug packaging device 3, and each of the drug packages 81 is formed. Perforations are formed between them for easy separation.

The drug packaging device 3 includes a control unit 31 that controls the drug packaging device 3 and a packaging printer 32 that prints information on the drug package 81. The control unit 31 includes a CPU, a ROM, a RAM, and the like. The package printer 32 has a user ID (an example of user identification information) indicating a person who takes a drug contained in the drug package 81 in the drug package 81 according to a control instruction from the control unit 31. , The first medicine distribution information including the time of taking the medicine contained in the medicine package 81 and the predetermined delivery destination identification information is printed. The delivery destination identification information is information such as a delivery destination ID or a delivery destination name indicating the LTCF B in which the drug user of the drug package 81 is occupying, and is registered in the user master described later. There is. In addition, instead of the character indicating the time of administration, or together with the character indicating the time of administration, a predetermined dose time code number (for example, a two-digit number) for each time of administration, a pictogram indicating the time of administration, etc. It is also conceivable that the image of is printed on the medicine bag 81. Here, the number of the dosing time code may be printed as a character, but when the medicine packaging device 3 has a function of printing the pictogram, the control unit 31 utilizes the function. It is also conceivable to print an image registered in advance as a numerical image of the dosing time code in place of the pictogram. This makes it possible to have the medicine package 81 print the number of the dosing time code in the existing system.

In particular, in the drug packaging device 3, the package printer 32 prints a code 811 (see FIG. 4) such as a one-dimensional code or a two-dimensional code indicating the first drug distribution information on the drug package 81. .. Here, the control unit 31 when printing the first drug distribution information on the drug package 81 using the package printer 32 is an example of the first recording means. As another embodiment, it is conceivable that the first drug distribution information is printed on a first recording medium such as a label attached to the drug package 81. It is also conceivable that the drug package 81 is attached with a first recording medium such as an IC tag. In this case, it is conceivable that the drug packaging device 3 is provided with a recording means such as an IC reader / writer that records the first drug distribution information on the first recording medium.

In addition, the drug packaging device 3 continuously packages the drug taken by one user into a series of the drug packages 81 at each time of administration, and a predetermined drug distribution process. It is possible to carry out a time-specific packaging process in which the medicines taken by a plurality of users belonging to the group are arranged according to the time of administration and continuously divided into a series of the above-mentioned medicine packages 81. In the drug packaging device 3, the code 811 is printed on each of the drug packages 81 by the packaging printer 32 regardless of whether the user-specific packaging process or the time-specific packaging process is executed. ..

When the time-specific packaging process is executed, it is conceivable that the series of drug packages 81 are delivered without being separated. Therefore, the package printer 32 is used to deliver only the first or last drug package 81. It is also conceivable that the code 811 is printed as another embodiment. In this case, in the containment time collation process (see FIG. 10) described later, the first drug distribution information printed on the first or last drug package 81 among the drug packages 81 connected at each time of administration is collated. Be the target.

[Printer 4]
The printer 4 is a medicine bag 82 used for collectively accommodating the medicine packages 81 of a plurality of users belonging to a predetermined medicine distribution group at the same dosing time (an example of a delivery container: see FIG. 4). It is used to print information on a label 821 (an example of a second recording medium: see FIG. 4) affixed to. Specifically, according to the control instruction from the dispensing support device 1, the printer 4 has a label 821, a dosing time corresponding to the medicine package 81 housed in the medicine bag 82, and predetermined delivery destination identification information. Print (record) the second drug distribution information including. In particular, the printer 4 prints a code 822 (see FIG. 4) such as a one-dimensional code or a two-dimensional code indicating the second drug distribution information on the label 821. The label 821 is used by being attached to the medicine bag 82. The delivery destination identification information is information indicating the LTCF B in which the drug user of the drug package 81 is occupying, and is registered in advance in the user master described later.

The label 821 is an example of a means for recording the second drug distribution information on the drug bag 82, and the printer 4 may directly print the second drug distribution information on the drug bag 82. Considered as a form. It is also conceivable that the medicine bag 82 is attached with a second recording medium such as an IC tag. In this case, it is conceivable that the dispensing support device 1 is provided with a recording means such as an IC reader / writer that records the second drug distribution information on the second recording medium. The printer 4 is also used to print a prescription corresponding to the prescription data according to the print data received from the dispensing support device 1.

[Dispensing support device 1]
The dispensing support device 1 is a personal computer including a control unit 11, a data storage unit 12, a communication interface 13, a display device 14, an operation device 15, a drive device 16, and the like. The single substance of the dispensing support device 1 may be regarded as a drug distribution support system according to the present invention. Further, a higher-level system (not shown) such as an electronic medical record system or a prescription input terminal for inputting prescription data to the dispensing support device 1 is connected to the dispensing support device 1 via the network N1. It should be noted that the dispensing support device 1 may be configured so that prescription data can be input using the operation device 15.

The control unit 11 includes a CPU, a ROM, a RAM, and the like. The CPU is a processor that controls the dispensing support device 1 by executing processing according to various control programs. The ROM is a non-volatile memory in which a program such as a BIOS executed by the CPU is stored in advance. The RAM is a volatile memory or a non-volatile memory used for the development of various control programs by the CPU and the temporary storage of data.

The data storage unit 12 is a non-volatile storage means such as a hard disk or SSD that stores various application programs and various data executed by the control unit 11. Specifically, the data storage unit 12 is subjected to a prescription data issuance process (see FIG. 5), a storage time collation process (see FIG. 10), a delivery time collation process (see FIG. 11), and the like, which will be described later, in the control unit 11. The dispensing support program to be executed is remembered.

For example, the control unit 11 functions as a second recording unit 111, a determination unit 112, and a first notification unit 113 by executing various processes according to the dispensing support program. Here, the second recording unit 111, the determination unit 112, and the control unit 11 when functioning as the first notification unit 113 are examples of a second recording unit, a determination unit, and a first notification unit.

The second recording unit 111 is used when the printer 4 is used to accommodate the medicine package 81 of a plurality of users belonging to the predetermined nursing care facility B (drug distribution group) at the same dosing time. The code 822, which is the second drug distribution information including the time of administration and the delivery destination identification information of the LTCF B, is printed (recorded) on the label 821 attached to the drug bag 82.

The determination unit 112 determines the dosing time and the delivery destination identification information of the first drug distribution information read from the medicine package 81, and the taking time and the delivery destination of the second drug distribution information read from the medicine bag 82. It is determined whether or not the identification information matches. The reading terminal 2 reads the first drug distribution information and the second drug distribution information.

The first notification unit 113 notifies the determination result of the determination unit 112. For example, the first notification unit 113 causes the reading terminal 2 or the display device 14 to display whether or not the determination results of the determination unit 112 match. It is also conceivable that the first notification unit 113 displays an error message only when the determination results of the determination unit 112 do not match.

In addition, various databases such as a drug master, a doser master, a pharmacist master, a prescription classification master, a clinical department master, and a ward master are also stored in the data storage unit 12. For example, the drug master includes a drug code, a drug name, a JAN code (or RSS), a drug bottle code, a classification (dosage form: powder, tablet, liquid medicine, external medicine, etc.), specific gravity, and drug type (ordinary drug, Includes information on poisons, narcotics, powerful drugs, antipsychotics, therapeutics, etc.), formulation changes, excipients, precautions, etc. In addition, the drug master also contains side effect related information regarding side effects that may occur on a drug-by-drug basis. As a result, in the dispensing support device 1, when the content of the side effect is selected, for example, the control unit 11 uses the side effect-related information and the prescription data for a drug that is likely to cause the side effect. It is also possible to carry out a suspected drug identification process to identify based on. In addition, the taker master includes the taker ID, name, gender, age, address, medical history, family information, clinical department, and hospitalization ward of each taker, as well as the above-mentioned long-term care facility B corresponding to the place of residence. Contains information such as delivery address identification information. It should be noted that the user is a concept including a resident who is occupying the LTCF B and a patient who is receiving medical treatment at a medical institution.

Further, the data storage unit 12 has a prescription data storage unit 121 and a drug distribution management information storage unit 122. The prescription data storage unit 121 stores the prescription data acquired from the higher-level system (not shown) in a database format. The prescription data includes, for example, prescription delivery date, order number, prescription classification, BCD, user ID, user name, user birth date, drug information (drug code, drug name, dose, etc.), dosage form, etc. Information such as information (internal use, external use, etc.), usage information (including time of administration), medical treatment type (outpatient, inpatient, etc.), clinical department, etc. are included.

The drug distribution management information storage unit 122 stores the drug distribution management information D1 in which the delivery destination identification information, the administration time, and the user identification information are associated with each other. Here, FIG. 2 is a diagram showing an example of the drug distribution management information D1. As shown in FIG. 2, in the drug distribution management information D1, the delivery date, the delivery destination ID and the old health facility name of the LTCF B, which is the delivery destination identification information, the dosing time, and the user identification information. The user ID and the name are stored in association with each other.

Specifically, the control unit 11 generates the drug distribution management information D1 based on the prescription data of a plurality of users input from the higher-level system (not shown) and the user master. The drug distribution management information D1 shown in FIG. 2 shows information corresponding to the dosing time for one day, but is not limited to this. For example, the control unit 11 generates the drug distribution management information D1 corresponding to an arbitrary predetermined dosing period that is simultaneously delivered from the pharmacy A to the LTCF B, such as for a plurality of days or one week. ..

Further, in the drug distribution management information D1 shown in FIG. 2, the case where two LTCFs B1 and LTCF B2 are registered as the LTCF B will be described as an example, but one or three or more will be described. The LTCF B may be registered in advance as a delivery destination. Further, in the present embodiment, the case where the LTCF B is set as one drug distribution group will be described. For example, in the LTCF B, a room or a floor in which a plurality of users are occupying is designated. It is also possible to set it as a drug group.

The communication interface 13 is a network that executes data communication wirelessly or by wire with the reading terminal 2, the chemical packaging device 3, and the printer 4 via the network N1 according to a predetermined communication protocol. Have a card etc. The display device 14 is a display means such as a liquid crystal display or an organic EL display that displays various information according to a control instruction from the control unit 11. The operating device 15 is an operating means operated by a user to input various information to the dispensing support device 1. Specifically, the operating device 15 includes a keyboard and a mouse (pointing device) that accept input operations of various information according to the display screen of the display device 14.

The drive device 16 can read the dispensing support program from a computer-readable recording medium 17 on which the dispensing support program is recorded. The recording medium 17 is a CD, DVD, BD, USB memory, or the like. Then, in the dispensing support device 1, the dispensing support program read from the recording medium 17 by the drive device 16 is installed in the data storage unit 12 by the control unit 11.

[Reading terminal 2]
The reading terminal 2 is a reading means such as a bar code reader that reads the first drug distribution information and the second drug distribution information from the code 811 and the code 822 attached to the medicine package 81 and the medicine bag 82. be. The first drug distribution information and the second drug distribution information read by the reading terminal 2 are input to the dispensing support device 1. When a first recording medium or a second recording medium such as an IC tag on which the first drug distribution information or the second drug distribution information is recorded is attached to the medicine package 81 or the medicine bag 82, the reading terminal. Reference numeral 2 is a reading means such as an IC reader / writer that reads information from the first recording medium or the second recording medium. Further, the reading terminal 2 may be a mobile terminal such as a mobile phone, a smartphone, a PDA, a media player, or a tablet terminal as long as information can be read from the code 811 and the code 822.

[Drug distribution support device 5]
On the other hand, the drug distribution support device 5 is a personal computer including a control unit 51, a data storage unit 52, a communication interface 53, a display device 54, an operation device 55, a drive device 56, and the like.

The control unit 51 includes a CPU, a ROM, a RAM, and the like. The CPU is a processor that controls the drug distribution support device 5 by executing processing according to various control programs. The ROM is a non-volatile memory in which a program such as a BIOS executed by the CPU is stored in advance. The RAM is a volatile memory or a non-volatile memory used for the development of various control programs by the CPU and the temporary storage of data.

The data storage unit 52 is a non-volatile storage means such as a hard disk or SSD that stores various application programs and various data executed by the control unit 51. Specifically, the data storage unit 52 has a drug distribution support program for causing the control unit 51 to execute a later-described receipt-time collation process (see FIG. 12), a drug-delivery time collation process (see FIG. 13), and the like. It is remembered.

For example, the control unit 51 functions as a display control unit 511, a delivery destination determination unit 512, and a second notification unit 513 by executing various processes according to the drug distribution support program. Here, the display control unit 511, the delivery destination determination unit 512, and the control unit 51 when functioning as the second notification unit 513 are examples of a display control means, a delivery destination determination unit, and a second notification unit. be.

When the first drug distribution information is read from the drug package 81, the display control unit 511 stores the face image of the user corresponding to the user ID of the first drug distribution information in the data storage unit 52. Read from and display. Specifically, the display control unit 511 receives the user based on the resident master described later stored in the master storage unit 521 when the first drug distribution information is read by the mobile terminal 6. The face image of the above is displayed on the mobile terminal 6.

The delivery destination determination unit 512 determines whether or not the delivery destination identification information of the second drug distribution information read from the medicine bag 82 at the delivery destination matches the delivery destination identification information corresponding to the delivery destination. judge. That is, the delivery destination determination unit 512 determines whether or not the delivery destination is correct as the delivery destination to which the medicine bag 82 should be delivered.

The second notification unit 513 notifies the determination result by the delivery destination determination unit 512. For example, it is conceivable that the second notification unit 513 causes the display device 54 or the reading terminal 7 to display whether or not the determination results of the delivery destination determination unit 512 match. It is also conceivable that the second notification unit 513 displays an error message only when the determination results of the delivery destination determination unit 512 do not match.

Further, the data storage unit 52 has a master storage unit 521 and a conversion information storage unit 522. The master storage unit 521 stores a resident master including information such as a resident ID, a resident name, a facial image, a medical history, or a drug history for the resident who is occupying the LTCF B. The facial image is registered in advance as an image such as a facial photograph or a caricature showing the appearance of the resident.

The conversion information storage unit 522 contains predetermined conversion information for realizing compatibility between the user master managed by the pharmacy A and the resident master managed by the LTCF B. It is remembered. For example, the conversion information is information indicating a correspondence relationship between the user ID and the resident ID. It is also conceivable that the user ID in the user master is a combination of the delivery destination identification information corresponding to the LTCF B and the resident ID.

As a result, in the drug distribution support device 5, the control unit 51 can convert the user ID in the user master managed by the pharmacy A into the resident ID based on the conversion information. It is possible. Therefore, in the drug distribution support system 10, the system on the pharmacy A side and the system on the LTCF B side can be configured separately, and the information of the resident master on the LTCF B side can be obtained. There is no need to tell Pharmacy A.

The communication interface 53 has a network card or the like that executes data communication wirelessly or by wire with the dispensing support device 1 or the like via the network N1 according to a predetermined communication protocol. The display device 54 includes display means such as a liquid crystal display or an organic EL display that displays various information according to a control instruction from the control unit 51, a speaker that outputs sound according to a control instruction from the control unit 51, and the like. This is an example of terminal display means. The operating device 55 is an operating means operated by the user to input various information to the drug distribution support device 5. Specifically, the operation device 55 includes a keyboard and a mouse (pointing device) that accept input operations of various information according to the display screen of the display device 54.

The drive device 56 can read the drug distribution support program from a computer-readable recording medium 57 in which the drug distribution support program is recorded. The recording medium 57 is a CD, DVD, BD, USB memory, or the like. Then, in the drug distribution support device 5, the drug distribution support program read by the drive device 56 from the recording medium 57 is installed in the data storage unit 52 by the control unit 51.

[Mobile terminal 6]
The mobile terminal 6 is, for example, a mobile phone, a smartphone, a PDA, a media player, a tablet terminal, or the like, and the medicine package 81 housed in the medicine bag 82 is distributed to a user at the health facility B. Carried by the drug clerk. The mobile terminal 6 includes a control unit 61 and a camera 62.

The control unit 61 includes a CPU, RAM, ROM, and the like, and controls the mobile terminal 6. In the mobile terminal 6, various processes are executed by the control unit 61 according to a pre-installed application program. The camera 62 is a photographing means for photographing an image or a moving image. The control unit 61 has a code reading function for reading a one-dimensional code or a two-dimensional code included in an image or video image taken by the camera 62. Specifically, the mobile terminal 6 can read information from the one-dimensional code or the two-dimensional code printed on the medicine package 81 and the medicine bag 82 by using the code reading function. Then, the control unit 61 transmits the information read by the camera 62 to the drug distribution support device 5. The mobile terminal 6 also includes a display unit for displaying various information and an operation unit for receiving various operations.

[Reading terminal 7]
Similar to the reading terminal 2, the reading terminal 7 is a reading means such as a bar code reader that reads information from a one-dimensional code or a two-dimensional code printed on the medicine package 81 or the medicine bag 82. Then, the information read by the reading terminal 7 is input to the drug distribution support device 5. When a recording medium such as an IC tag is attached to the medicine package 81 or the medicine bag 82, the reading terminal 7 is a reading means such as an IC reader / writer that reads information from the recording medium. It is also possible to use the mobile terminal 6 as the reading terminal 7 and omit the reading terminal 7.

[Example of drug distribution work]
Subsequently, with reference to FIGS. 3 and 4, the flow of the drug distribution work executed in the pharmacy A and the LTCF B in which the drug distribution support system 10 is used will be described. Specifically, steps S1 to S5 shown in FIG. 3 are performed at the pharmacy A, and steps S6 to S7 are performed at the LTCF B. Note that FIG. 4 is a diagram schematically showing the flow of the drug distribution work when the drug is delivered from the pharmacy A to the LTCF B1 and the LTCF B2, which are examples of the LTCF B.

<Step S1>
First, in the dispensing support device 1, the control unit 11 selects the LTCF B to deliver the drug according to the user operation of the operating device 15, and issues prescription data corresponding to the LTCF B. The prescription data issuance process is executed (S1).

<Step S2>
Then, in the dispensing support device 1, the control unit 11 generates packaging data based on each of the prescription data issued in step S1, and inputs the packaging data to the drug packaging device 3. As a result, automatic dispensing by the drug packaging device 3 is started (S2). As a result, as shown in FIG. 4, each of the medicine packages 81 containing the medicines taken by the users belonging to each of the LTCF B is obtained.

Further, in the step S2, in the drug packaging device 3, the control unit 31 uses the packaging printer 32 to obtain the code 811 indicating the first drug distribution information as shown in FIG. Print on the medicine package 81. The first drug distribution information includes the user ID, the time of administration, and the delivery destination identification information. The name of the person taking the medicine, the date and time of taking the medicine, the time of taking the medicine, and the like are also printed on the medicine package 81.

Further, in step S2, the control unit 11 uses the printer 4 to attach the code 822 indicating the second drug distribution information to the drug bag 82, as shown in FIG. 4. To print. The second drug distribution information includes the dosing time and the delivery destination identification information. In addition, the name of the LTCF, the date and time of administration, the time of administration, and the like are also printed on the medicine bag 82.

<Step S3>
When the dispensing work by the drug packaging device 3 is completed, the pharmacist in charge of inspection subsequently inspects the drug dispensed by the drug packaging device 3 (S3). For the inspection, it is conceivable to use an image inspection system that images the medicine dispensed by the medicine packaging device 3 and automatically performs the inspection based on the captured image. For example, when the time-specific packaging process is executed in the drug packaging process, the image inspection system divides the images of the drug packages 81 arranged for each time of administration in the LTCF unit, and the image is divided. An inspection image is generated, which is arranged for each user according to the time of administration. Then, the image inspection system inspects the medicine dispensed by the medicine packaging device 3 based on the inspection image.

<Step S4>
Next, as shown in FIG. 4, the delivery person accommodates each of the medicine packages 81 to be delivered to each of the LTCF B in the medicine bag 82 corresponding to the time of administration of the medicine package 81 and the delivery destination (the delivery person). S4). At this time, the person in charge of delivery reads the first drug distribution information and the second drug distribution information from each of the medicine package 81 and the medicine bag 82 by using the reading terminal 2. As a result, the control unit 11 of the dispensing management device 1 determines whether or not the first drug distribution information and the second drug distribution information match in the accommodation time collation process described later.

<Step S5>
After that, the delivery person delivers each of the medicine bags 82 to the delivery destination (S5). At this time, the person in charge of delivery reads the second drug distribution information from each of the drug bags 82 using the reading terminal 2. As a result, the control unit 11 of the dispensing management device 1 determines whether or not there is a leak in the medicine bag 82 to be delivered to the delivery destination in the delivery time collation process described later.

<Step S6>
Next, at each of the LTCFs B, when each of the drug bags 82 is received from the pharmacy A, the person in charge of drug distribution reads the second drug distribution information from the code 822 of the drug bag 82 using the reading terminal 7. (S6). As a result, the control unit 51 of the drug distribution support device 51 delivers the delivery destination identification information included in the second drug distribution information and the delivery of the LTCF B in which the reading terminal 7 is arranged in the drug receiving process described later. It is determined whether or not the destination identification information matches.

<Step S7>
After that, the person in charge of drug distribution at the LTCF B distributes each of the drug packages 81 contained in the drug bag 82 corresponding to the time of administration to the resident at each time of administration (S7). At this time, in the drug distribution work, the medicine packages 81 of the plurality of users are collectively housed in the medicine bag 82 for each time of taking, and therefore, at the delivery destination, the LTCF B, for each time of taking. It is possible to take out the medicine package 81 of a plurality of users from the medicine bag 82 and easily administer the medicine to each of the users. Further, in step S7, the person in charge of drug distribution reads the first drug distribution information from each of the drug packages 81 using the mobile terminal 6. As a result, the control unit 51 of the drug distribution support device 51 is the resident corresponding to the user ID based on the user ID included in the first drug distribution information in the drug distribution time collation process described later. The face image 63 is read from the user information storage unit 521 of the data storage unit 52 and displayed on the portable terminal 6.

[Various processes executed by the drug distribution support system 10]
Hereinafter, with reference to FIGS. 5 to 13, an example of various processes executed in the drug distribution support system 10 when the drug distribution operation (see FIG. 3) is executed will be described. The execution subject of various processes executed in the drug distribution support system 10 is not limited to those described here, and may be executed by the control unit of various devices constituting the drug distribution support system 10.

[Prescription data issuance process]
First, with reference to FIG. 5, the prescription data issuance process executed by the control unit 11 of the dispensing support device 1 in the step S1 will be described.

<Step S11>
In step S11, the control unit 11 determines whether or not the prescription data issuance operation has been performed for the one or the plurality of LTCFs B. Specifically, the control unit 11 selects one or a plurality of the LTCFs B according to the user operation of the operating device 15 in the dispensing support device 1, and issues prescription data for each of the LTCFs B. Accept. Then, when the prescription data issuance operation is performed (S11: Yes), the process proceeds to step S12. Until the prescription data issuance operation is performed (S11: No), the process waits in step S11.

<Step S12>
In step S12, the control unit 11 decomposes and arranges the prescription data of each of the users belonging to each of the LTCF B for each time of the same administration in the LTCF to which the LTC belongs. Generate.

For example, as shown in FIG. 6, the control unit 11 generates group prescription data in which prescription data of a plurality of users belonging to each of "Long-Term Care Health Facility B1" and "Long-Term Care Health Facility B2" are grouped. After that, as shown in FIG. 7, the control unit 11 arranges prescription data corresponding to each of the users belonging to "Long-Term Care Health Facility B1" and "Long-Term Care Facility B2" for each dosing time based on the group prescription data. Generate the changed packaging data. In addition, the packaged data includes data (empty data) indicating that even for a user who does not have a drug corresponding to the time of administration.

<Step S13>
Then, in step S13, the control unit 11 outputs the packaging data to the drug packaging device 3. As a result, in the chemical packaging device 3, the chemical packaging process (see FIG. 8) described later is executed according to the packaging data. As another embodiment, it is conceivable to print out a one-dimensional code or a two-dimensional code indicating the packaged data by the printer 4 or the like to which the dispensing support device 1 is connected. As a result, the chemical packaging device 3 can perform the packaging operation according to the packaging data by reading the packaging data from the printed paper with a harcode reader or the like.

[Chemical packaging process]
Next, with reference to FIG. 8, the drug packaging process executed by the control unit 31 of the drug packaging device 3 in the step S2 will be described. In the present embodiment, the case where the time-specific packaging process is executed as the drug packaging process will be described as an example, but the user-specific packaging process may be executed.

<Step S21>
First, in step S21, the control unit 31 waits for the input of the packaged data from the dispensing support device 1 (S21: No). Then, when it is determined that the packaged data has been input (S21: Yes), the control unit 31 shifts the process to step S22.

<Step S22>
In step S22, the control unit 31 sets the first LTCF B1 of the packaged data as a package target. Specifically, when the packaged data shown in FIG. 7 is input, the control unit 11 sets the “Long-Term Care Health Facility B1” as the package target in the first step S22. Then, when the step S22 is executed from the second time onward, the control unit 11 sets the second and subsequent hospital rooms as packaging targets in order. That is, when the packaging data shown in FIG. 7 is input, the control unit 31 sets the “Long-Term Care Health Facility B2” as the packaging target in the second step S22.

<Step S23>
In step S23, the control unit 31 starts packaging with the first dosing time corresponding to the LTCF B selected as the packaging target in step S22 of the packaging data as the packaging target. ..

Specifically, when the packaged data shown in FIG. 7 is input, the control unit 31 takes the “△ month △ day after breakfast” of the “Long-Term Care Health Facility B1” in the first step S23. Is started as a packaging target. Then, when the step S23 is executed from the second time onward, the control unit 31 starts the packaging in order for the second and subsequent administration times. That is, when the packaged data shown in FIG. 7 is input, the control unit 31 sets the time to take "△ month △ day after lunch" of "Long-Term Care Health Facility B1" in the second step S23. Start the packaging as the target for packaging.

Here, FIG. 9A is a diagram showing an example of the packaging result when the drug packaging process is executed based on the packaging data shown in FIG. 7. In the packaging results shown in FIG. 9A, the medicines taken by a plurality of users belonging to the same LTCF B are continuously packaged at each time of administration. Specifically, the medicine package 81 corresponding to the users "Ichiro Yuyama", "Jiro Yuyama", and "Saburo Yuyama" of the LTCF B1 is continuously distributed after breakfast, lunch, and dinner on △ Month △ days. Is formed. After the △ month △ day, the next day △ month □ day is also packaged in the same manner.

Further, when the prescription data includes information (type, time of use, etc.) of an unpackaged drug such as eye drops, liquid medicine, or an external medicine that is not packaged in the drug package 81, the packaged data includes the information. It is conceivable that the information on the non-packaging drug is included in addition to the data of the drug packaged by the drug packaging device 3. In this case, the control unit 31 texts or pictograms information such as the presence of the extra-packed drug and the content of the extra-packed drug in the drug package 81 corresponding to the time when the extra-packed drug is used. It is conceivable to print with (image). As a result, the presence of the extra-packaged drug can be easily grasped when the drug package 81 is distributed, and it is possible to prevent forgetting to use the extra-packaged drug. Further, even when the medicine package 81 corresponding to the time of use of the medicine outside the package does not exist, the control unit 31 outputs the empty medicine package 81 and the medicine outside the package is stored in the medicine package 81. It is conceivable to print information such as the existence and the contents of the unpacked drug in characters or pictograms (images). As a result, even if there is an extra-packed drug that should be used at a time different from the time when the drug package 81 is taken, the presence of the extra-packed drug can be easily grasped by referring to the drug package 81. It is possible to prevent forgetting to use the extra-packed drug.

<Step S24>
Next, in step S24, the control unit 31 sequentially determines whether or not there is a drug to be taken at the time of taking the data of each of the users included in the packaged data. Then, the control unit 31 shifts the process to step S241 when there is no drug to be taken at the time of administration in the data, that is, when the data is empty data (S24: No). On the other hand, if the data contains a drug to be taken at the time of administration, that is, if the data is not empty data (S24: Yes), the process is shifted to step S25.

<Step S25>
In step S25, the control unit 31 executes a packaging operation for the data included in the packaging data. Specifically, the control unit 31 prints the name and time of taking the drug and the code 811 indicating the first drug distribution information on the drug package 81 by the package printer 32, and prints the data on the data. The corresponding drug is packaged in the drug package 81.

<Step S241>
On the other hand, in step S241, the control unit 31 creates an empty medicine package 81 printed by the packaging printer 32 to the effect that there is no medicine to be taken at the time of administration. Specifically, the name and time of taking the drug, the code 811 and the information indicating that there is no drug (there is no drug) are printed on the empty drug package 81.

<Step S26>
Then, in step S26, the control unit 31 determines whether or not the packaging for the same dosing time started in step S23 has been completed. Here, when it is determined that the packaging at the same dosing time has been completed (S26: Yes), the control unit 31 shifts the process to step S27. On the other hand, if it is determined that the packaging at the same dosing time has not been completed (S26: No), the control unit 31 returns the process to the step S24.

<Step S27>
In step S27, the control unit 31 determines whether or not the packaging of the same LTCF B set as the packaging target in step S22 at the entire administration time has been completed. Here, when it is determined that the packaging for the entire dosing time has been completed (S27: Yes), the control unit 31 shifts the process to step S28. On the other hand, if it is determined that the packaging for all the doses has not been completed (S27: No), the control unit 31 shifts the process to step S271.

<Step S271>
In step S271, the control unit 31 executes a sachet division process for clearly indicating the timing at which the dosing time is switched, and returns the process to the step S23. For example, the delimiter process is to provide one empty medicine package 81. As a result, it is possible to easily grasp the timing of switching the dosing time in the drug package sheet in which the drug package 81 is continuously formed, which is obtained as a result of packaging by the drug packaging process. In addition, various information for drug inspection and inspection regarding the contents of each drug package 81 connected in front of the empty drug package 81 may be printed. Further, the separating process may be to cut once the medicine package sheet in which the medicine package 81 is continuously formed. As a result, the drug packaging device 3 can automatically obtain a continuum of the drug packages 81 for each time of administration. It should be noted that omitting the delimiter process is also considered as another embodiment.

<Step S28>
Then, in step S28, it is determined whether or not the packaging for all the LTCFs B included in the packaging data has been completed. Here, when it is determined that the packaging of each of the LTCF B has been completed (S28: Yes), the control unit 31 ends the series of the drug packaging processing and returns the processing to the step S21. On the other hand, if it is determined that the packaging of each of the LTCF B has not been completed (S28: No), the control unit 31 shifts the process to the step S22 and performs the next packaging operation for the LTCF B. Start.

In the present embodiment, the case where the time-specific packaging process is executed in the drug packaging process has been described as an example, but the user-specific packaging process is executed in the drug packaging process. You may. Here, FIG. 9B is a diagram showing the results of packaging when the user-specific packaging treatment is executed for the “Long-Term Care Health Facility B1” according to the group prescription data shown in FIG. According to the result of packaging shown in FIG. 9B, the medicines taken by one user are continuously packaged at each time of administration. Specifically, in the example shown in FIG. 9B, the user "Ichiro Yuyama" has breakfast, lunch, and supper on △ month △ day, and after breakfast, lunch, and dinner on △ month □ day, respectively. The medicine package 81 corresponding to the above is continuously formed. Then, after the user "Ichiro Yuyama", similarly, the drug package 81 corresponding to each time of administration is continuously formed for the user "Jiro Yuyama" belonging to the same LTCF B1.

[Verification processing at the time of accommodation]
Subsequently, with reference to the flowchart of FIG. 10, the accommodation time collation process executed by the control unit 11 of the dispensing support device 1 in the step S3 will be described.

When the user-specific packaging process is executed, each of the drug packages 81 is separated and stored in each of the drug bags 82 when the drug package 81 is stored in the drug bag 82 in step S3. To. On the other hand, when the time-specific packaging process is executed, each of the drug packages 81 may be separated and stored in each of the drug bags 82 when the drug package 81 is stored in the drug bag 82 in step S3. However, the plurality of the medicine packages 81 which are connected at each time of administration may be stored in the medicine bag 82 without being separated. By such a storage operation, the pharmacy A prepares a plurality of the medicine bags 82 in which the medicine packages 81 of the plurality of medication recipients corresponding to each time of administration are collectively stored.

<Step S31>
In step S31, the control unit 11 determines whether or not the second drug distribution information has been read from the code 822 of the drug bag 82 by the reading terminal 2. Here, when the control unit 11 determines that the second drug distribution information has been read (S31: Yes), the process shifts to step S32. On the other hand, until the second drug distribution information is read (S31: No), the process waits in the step S31. The control unit 11 determines the difference between the first drug distribution information of the drug package 81 and the second drug distribution information of the drug bag 82, for example, the presence or absence of the user ID that exists only in the first drug distribution information. It is possible to judge according to. Of course, the first drug distribution information and the second drug distribution information may include information that can be identified.

<Step S32>
In step S32, the control unit 11 receives the medicine package 81 housed in the same medicine bag 82 based on the second medicine distribution information of the medicine bag 82 read in step S31 and the medicine distribution management information D1. One or more of the above-mentioned medicine packages 81 are specified as predetermined. Specifically, the control unit 11 accommodates the drug of the user ID whose delivery destination identification information and the dosing time are the same as those of the second drug distribution information in the drug distribution management information D1. The 81 is specified as the medicine package 81 to be housed in the medicine bag 82.

<Step S33>
Then, in step S33, the control unit 11 determines whether or not the first drug distribution information has been read from the code 811 of the drug package 81 by the reading terminal 2. Here, when the control unit 11 determines that the first drug distribution information has been read (S33: Yes), the process shifts to step S34 until the first drug distribution information is read (S33). : No), the determination in step S33 is repeated.

<Step S34>
In step S34, the control unit 11 delivers the delivery destination identification information of the second drug distribution information read in step S31, the dosing time, and the first drug distribution information read in step S33. It is determined whether or not the prior identification information and the time of administration match. Here, the step S34 is a process executed by the determination unit 112 of the control unit 11. Further, in the step S34, the control unit 11 stores the first drug distribution information read in the step S33 and the determination result in the step S34 in the data storage unit 12 as a reading history. Thereby, the dispensing support device 1 can refer to and output the reading history.

<Step S35>
Then, in step S35, the control unit 11 notifies the determination result in step S34. Here, the step S35 is a process executed by the first notification unit 113 of the control unit 11. Specifically, the control unit 11 notifies the user of the determination result by displaying the determination result on the display device 14 or the reading terminal 2. As a result, the user can recognize the determination result. Therefore, human error in the drug distribution work in which the drug packages 81 of a plurality of users are collectively stored in the drug bag 82 at each time of administration and delivered to the delivery destination is suppressed. The method of notifying the determination result is not limited to the display, and the determination result may be notified by voice or a light emitting mode.

<Step S36>
After that, in step S36, the control unit 11 determines whether or not to end the reading operation of the first drug distribution information from the drug package 81 housed in the drug bag 82 by the reading terminal 2. Specifically, the control unit 11 ends the reading operation when the user continuously operates the reading terminal 2 or the next operation of reading the first drug distribution information from the drug package 81 is performed. It is determined not to do so (S36: No), and the process is shifted to the step S33. As a result, the reading of the first drug distribution information from each of the drug packages 81 housed in the drug bag 82 is executed in order. On the other hand, the control unit 11 receives an end signal from the reading terminal 2 in response to a user's ending operation on the reading terminal 2, or from the medicine bag 82 different from the medicine bag 82 read in step S31. When the second drug distribution information is read, it is determined that the reading operation is completed (S36: Yes), and the process is shifted to step S37.

<Step S37>
In step S37, the control unit 11 determines whether or not the first drug distribution information has been read from all the drug packages 81 to be contained in the same drug bag 82 based on the drug distribution management information D1. do. Here, the step S37 is a process executed by the determination unit 112 of the control unit 11. Here, when the control unit 11 determines that the first drug distribution information has been read from all the drug packages 81 to be stored in the drug bag 82 (S37: Yes), the control unit 11 ends the storage time collation process. The process returns to step S31. When it is determined that the reading is completed by reading the second drug distribution information from the different drug bag 82, the same process is executed based on the second drug distribution information in the subsequent step S31 and subsequent steps. On the other hand, when the control unit 11 determines that the first drug distribution information has not been read from all the drug packages 81 to be contained in the drug bag 82 (S37: No), the process shifts to step S38.

<Step S38>
In step S38, the control unit 11 notifies the determination result in step S37 and returns the process to step S33. Specifically, the control unit 11 indicates that, based on the drug distribution management information D1, the drug package 81 to be accommodated in the drug bag 82 includes the drug package 81 that has not been read in step S33. And the unread information of the drug package 81 is displayed on the display device 14 or the reading terminal 2. As a result, the leakage of the medicine package 81 into the medicine bag 82 is suppressed. For example, the control unit 11 displays the ID or name of the user corresponding to the drug package 81, which is not read in step S33, among the drug packages 81 to be accommodated in the drug bag 82, together with the time of administration. ..

[Delivery time verification process]
Subsequently, with reference to the flowchart of FIG. 11, the delivery time collation process executed by the control unit 11 of the dispensing support device 1 in the step S5 will be described.

<Step S41>
In step S41, the control unit 11 determines whether or not the delivery destination identification information has been input by the reading terminal 2. Specifically, the delivery person inputs the delivery destination identification information indicating the LTCF B, which is the delivery destination of the medicine bag 82 to be shipped, to the reading terminal 2. Further, the delivery person uses the reading terminal 2 to read the delivery destination identification information previously attached to a container such as a container to be accommodated when the medicine bag 82 to be shipped is delivered, thereby reading the delivery destination. It is also possible to enter identification information. Here, when the control unit 11 determines that the delivery destination identification information has been input (S41: Yes), the process shifts to step S42. On the other hand, until the delivery destination identification information is input (S41: No), the process waits in the step S41.

<Step S42>
In step S42, the control unit 11 simultaneously delivers to the same LTCF B indicated by the delivery destination identification information based on the delivery destination identification information and the drug distribution management information D1 input in the step S41. Identify one or more of the drug bags 82 to be done. Specifically, the control unit 11 specifies the medicine bag 82 having the same delivery destination identification information and the same delivery date as the medicine bag 82 to be delivered to the LTCF B at the same time.

<Step S43>
Then, in step S43, the control unit 11 determines whether or not the second drug distribution information has been read from the code 822 of the drug bag 82 by the reading terminal 2. Here, when the control unit 11 determines that the second drug distribution information has been read (S43: Yes), the process shifts to step S44 until the second drug distribution information is read (S43). : No), the determination in step S43 is repeated.

<Step S44>
In step S44, the control unit 11 determines whether or not the delivery destination identification information input in step S41 and the delivery destination identification information of the second drug distribution information read in step S43 match. judge. Here, the step S44 is a process executed by the determination unit 112 of the control unit 11. Further, in the step S44, the control unit 11 stores the second drug distribution information read in the step S43 and the determination result in the step S44 in the data storage unit 12 as a reading history. Thereby, the dispensing support device 1 can refer to and output the reading history.

<Step S45>
Then, in step S45, the control unit 11 notifies the determination result in step S44. Here, the step S45 is a process executed by the first notification unit 113 of the control unit 11. Specifically, the control unit 11 notifies the user of the determination result by displaying the determination result on the display device 14 or the reading terminal 2. As a result, the user can recognize the determination result. Therefore, human error in the drug distribution work in which the drug packages 81 of a plurality of users are collectively stored in the drug bag 82 at each time of administration and delivered to the delivery destination is suppressed. The method of notifying the determination result is not limited to the display, and the determination result may be notified by voice or a light emitting mode.

<Step S46>
After that, in step S46, the control unit 11 determines whether or not to end the reading operation of the second drug distribution information from the drug bag 82 delivered to the same LTCF B by the reading terminal 2. Specifically, the control unit 11 does not end the reading operation when the user continuously operates the reading terminal 2 or the next operation of reading the second drug distribution information from the drug bag 82 is performed. (S46: No), and the process is shifted to the step S43. As a result, the second drug distribution information is sequentially read from each of the drug bags 82 delivered to the same LTCF B. On the other hand, the control unit 11 is different from the delivery destination identification information input when the end signal is input from the reading terminal 2 in response to the user's end operation for the reading terminal 2 or in the step S41. When the delivery destination identification information is input, it is determined that the reading operation is completed (S46: Yes), and the process proceeds to step S47.

<Step S47>
In step S47, the control unit 11 distributes the second drug from all the drug bags 82 to be simultaneously delivered to the same LTCF B corresponding to the delivery destination identification information based on the drug distribution management information D1. Determine if the information has been read. Here, the step S47 is a process executed by the determination unit 112 of the control unit 11. Here, when the control unit 11 determines that the second drug distribution information has been read from all the drug bags 82 to be delivered to the LTCF B at the same time (S47: Yes), the delivery time collation process is terminated. The process proceeds to step S41. If it is determined that the reading is completed by inputting different delivery destination identification information, the same processing is executed based on the delivery destination identification information in the subsequent steps S41 and subsequent steps. On the other hand, when the control unit 11 determines that the second drug distribution information has not been read from all the drug bags 82 to be delivered to the LTCF B at the same time (S47: No), the process shifts to step S48. ..

<Step S48>
In step S48, the control unit 11 notifies the determination result in the step S47 and returns the process to the step S43. Specifically, the control unit 11 is not read in step S43 of the medicine bag 82 to be delivered to the LTCF B corresponding to the delivery destination identification information at the same time based on the medicine distribution management information D1. The display device 14 or the reading terminal 2 displays the fact that the medicine bag 82 exists and the information of the unread medicine bag 82. As a result, the omission of delivery of the medicine bag 82 to the LTCF B is suppressed. For example, the control unit 11 delivers the time to take the medicine bag 82, which is not read in step S43, among the medicine bags 82 to be delivered to the LTCF B corresponding to the delivery destination identification information at the same time. Display with the destination identification information.

[Processing at the time of receipt]
Next, with reference to the flowchart of FIG. 12, an example of the procedure of the receiving-time processing executed by the control unit 51 of the drug distribution support device 5 in the step S6 will be described.

<Step S51>
In step S51, the control unit 51 determines whether or not the second drug distribution information has been read from the drug bag 82. Here, the process waits in step S51 until the second drug distribution information is read from the drug bag 82 (S51: No). On the other hand, when it is determined that the second drug distribution information has been read from the drug bag 82 (S51: Yes), the process proceeds to step S52.

<Step S52>
In step S52, the control unit 51 indicates the delivery destination identification information included in the second drug distribution information read in step S51 and the LTCF B in which the drug distribution support device 5 is installed. It is determined whether or not the information matches the delivery destination identification information registered in advance in the drug distribution support device 5. Here, the step S52 is a process executed by the delivery destination determination unit 512 of the control unit 51. Further, in the step S52, the control unit 51 stores the second drug distribution information read in the step S51 and the determination result in the step S52 in the data storage unit 52 as a reading history. As a result, the drug distribution support device 5 can refer to and output the reading history.

<Step S53>
Then, in step S53, the control unit 51 notifies the determination result in step S52. Specifically, the control unit 51 causes the display device 54 or the reading terminal 7 to display the determination result. Here, the step S53 is a process executed by the second notification unit 513 of the control unit 51. As a result, the person in charge of drug distribution can easily and surely recognize that the LTCF B is correct as the delivery destination of the drug bag 82 by confirming the determination result. Therefore, erroneous delivery of the medicine bag 82 is suppressed.

[Collaboration processing at the time of drug distribution]
Next, with reference to the flowchart of FIG. 13, an example of the procedure of the drug distribution time collation process executed by the control unit 51 of the drug distribution support device 5 in the step S7 will be described.

<Step S61>
In step S61, the control unit 51 determines whether or not the first drug distribution information has been read from the drug package 81. Here, the process waits in step S61 until the first drug distribution information is read from the drug package 81 (S61: No). On the other hand, when it is determined that the first drug distribution information has been read from the drug package 81 (S61: Yes), the process proceeds to step S62.

<Step S62>
In step S62, the control unit 51 corresponds to the user based on the user ID, the conversion information, and the resident master included in the first drug distribution information read in step S61. Identify the person. Further, in the step S62, the control unit 51 stores the first drug distribution information read in the step S61 and the specific result in the step S62 in the data storage unit 52 as a reading history. As a result, the drug distribution support device 5 can refer to and output the reading history.

<Step S63>
Then, in step S63, the control unit 51 transfers the time of taking the medicine package 81 and the name and face image 63 of the resident corresponding to the person specified in step S62 to the mobile terminal 6. Display (see FIG. 4). Here, the step S63 is a process executed by the display control unit 511 of the control unit 51. As a result, the person in charge of drug distribution can easily and surely recognize that the resident is correct as a person taking the medicine of the medicine package 81 by checking the face image 63 of the resident. Therefore, drug distribution mistakes by the person in charge of drug distribution are suppressed. Further, according to the configuration of the drug distribution support system 10, by displaying the face image 63, it is not necessary for each of the residents to wear a wristband or the like for identifying the resident. It is suitable for the operation of the LTCF B. As another embodiment, it is conceivable that a plurality of the facial images 63 having different facial expressions or shooting angles for one resident are registered in advance in the resident master. As a result, the person in charge of drug distribution can more accurately determine the resident based on each of the facial images 63.

[Second Embodiment]
As described above, in the drug distribution work of step S7 performed at the LTCF B, the drug is distributed while the drug and the resident are collated by the drug distribution staff. Hereinafter, in the present embodiment, a configuration for suppressing human error at the time of drug distribution will be described by supporting the drug distribution work by the person in charge of drug distribution.

First, the configuration of the drug distribution support system 100 according to the present embodiment will be described with reference to FIG. 14. Regarding the drug distribution support system 100, the same reference numerals are given to the same configurations as the drug distribution support system 10 (see FIG. 1), and the description thereof will be omitted.

As shown in FIG. 14, the dispensing support device 1 includes a USB port 18. The USB port 18 has a detachable USB memory 19, and can write data to the USB memory 19 and read data from the USB memory 19. In addition to the USB memory 19, other recording media such as CDs, DVDs, and BDs may be used.

Further, in the dispensing support device 1, the control unit 11 functions as a drug distribution data output unit 114, a residual drug information input unit 115, and a residual drug notification unit 116 by executing various processes according to the dispensing support program. do. The drug distribution data output unit 114 is an example of the drug distribution data output means, the residual drug information input unit 115 is an example of the residual drug information input means, and the residual drug notification unit 116 is an example of the residual drug notification means.

The drug distribution data output unit 114 is used when packaging a drug into each of the drug packages 81, and outputs drug distribution data based on the prescription data stored in the prescription data storage unit 121 to the USB port 18. However, it is possible to record data from the USB port 18 to the USB memory 19. In particular, the drug distribution data output unit 114 can output the drug distribution data in units of the drug distribution group. Specifically, when the LTCF B is designated by a user operation on the operating device 15, the drug distribution data output unit 114 outputs prescription data corresponding to each resident occupying the LTCF B. It is possible to extract and output drug distribution data based on the prescription data. Thereby, it is possible to easily use only the necessary prescription data among the prescription data.

Therefore, the facility master and the resident master are stored in the data storage unit 12 of the dispensing support device 1, and the drug distribution data output unit 114 is required based on the facility master and the resident master. The prescription data is extracted. The drug distribution data output unit 114 can also add a part or all of the information of the facility master and the resident master to the drug distribution data and output the data.

Here, FIG. 15 is a diagram showing an example of the facility master and the resident master. The registration work of each of the facility master and the resident master is performed by using the display device 14 and the operation device 15 of the dispensing support device 1, for example, in the initial setting or master maintenance of the dispensing support device 1. Will be done.

As shown in FIG. 15, the facility master stores the facility code, facility name, and print format corresponding to each of the LTCF B in association with each other. The facility code and the facility name are examples of identification information for identifying the LTCF B, and the print format is a type of format of items to be printed on the medicine package 81 in the drug packaging device 3. Information for identifying. The facility code is, for example, the same as the delivery destination ID (see FIG. 2).

Further, as shown in FIG. 15, each of the resident masters is stored in association with each of the LTCFs B registered in the facility master. Specifically, the resident master stores the occupant ID, the occupant name, the resident ID, the group, and the print format corresponding to each resident. The user ID, the user name, and the resident ID are examples of identification information for identifying the resident who resides in the LTCF B. In particular, the user ID is identification information registered in advance in order to identify the resident (taker) in the dispensing support device 1 or the like on the pharmacy A side, and the resident ID is the LTCF. This is identification information registered in advance in order to identify the resident in the drug distribution support device 5 or the like on the B side. For example, the resident master stored in the master storage unit 521 is provided from the LTCF B side to the pharmacy A side, so that the pharmacy A side becomes the resident master of the dispensing support device 1. The resident ID is registered. The correspondence between the occupant ID and the resident ID in the resident master is the same as the correspondence between the occupant ID and the resident ID in the conversion information used in the drug distribution support device 5. Is.

Further, the group is identification information for identifying a group classified as a series of drug distribution groups by a ward, a hospital room, a floor, or the like in the LTCF B. In the LTCF B, drug distribution work to residents is performed for each group. Further, the print format is information for identifying the type of format such as items and arrangements to be printed on the medicine package 81, the medicine bag 82, and the like in the medicine packaging device 3. The print format registered in the resident master is preferentially adopted even when the print format is registered in the facility master, for example.

In the drug distribution support system 100 configured in this way, it is possible to grasp the correspondence relationship between the user ID and the resident ID in the dispensing support device 1. Therefore, the control unit 11 causes the drug packaging device 3 to print the resident ID on the drug package 81 in place of the drug recipient ID included in the first drug distribution information or together with the drug recipient ID. Is possible.

Further, the residual drug information input unit 115 can input the residual drug information output by the residual drug information output unit 516 described later in the drug distribution support device 5. For example, the residual drug information input unit 115 requests the drug distribution support device 5 to transmit the residual drug information via the network N1 and the network N2, and is transmitted from the drug distribution support device 5. Acquire the remaining drug information. Further, the residual drug information input unit 115 can also read and input the residual drug information from a recording medium such as the USB memory 19, and the residual drug transmitted from the drug distribution support device 5 by mail or the like. It is also possible to enter drug information.

The remaining drug notification unit 116 notifies the information of the remaining drug that can be used as the prescription drug included in the prescription data based on the remaining drug information input by the remaining drug information input unit 115 and the prescription data. It is possible. For example, the residual drug notification unit 116 can display a warning that there is a residual drug that can be used in the prescription data to be dispensed in the prescription data issuance process (step S1 in FIG. 4). Is. In the dispensing support device 1, the control unit 11 can display the remaining drug information on the display device 14 or the like at an arbitrary timing according to the user operation of the operation device 15. Further, the remaining drug notification unit 116 can also transmit the remaining drug information to a higher-level system (not shown) such as the electronic medical record system or the prescription input terminal communicatively connected to the dispensing support device 1. Is. As a result, it is possible to notify the doctor who uses the higher-level system of the remaining drug information and urge the correction of the prescription data, etc., and it is possible to suppress the waste of the drug. The pharmacist on the pharmacy A side refers to the remaining drug information displayed on the dispensing support device 1, informs the doctor of the amount of the remaining drug, and inputs the prescription excluding the remaining drug when inputting a new prescription. It is possible to encourage correction (reissue) by removing the remaining medicine from the entered prescription.

On the other hand, as shown in FIG. 14, the drug distribution support device 5 includes a USB port 58. The USB memory 19 can be attached to and detached from the USB port 58, and data can be written to and read from the USB memory 19.

Further, in the drug distribution support device 5, the data storage unit 52 includes a drug distribution data storage unit 523. The drug distribution data storage unit 523 stores the drug distribution data output from the dispensing support device 1 and read from the USB memory 19 by the USB port 58.

Further, in the drug distribution support device 5, the control unit 51 executes various processes according to the drug distribution support program to execute a drug distribution data input unit 514, a medication completion input unit 515, and a residual drug information output unit 516. Functions as. The drug distribution data input unit 514 is an example of the drug distribution data input means, the medication completion input unit 515 is an example of the medication completion input means, and the residual drug information output unit 516 is an example of the residual drug information output means.

The drug distribution data input unit 514 can input the drug distribution data output by the dispensing support device 1 to the drug distribution support device 5 provided in the LTCF B, which is the delivery destination of the drug. Is. Specifically, the medicine distribution data input unit 514 reads the medicine distribution data from the USB memory 19 connected to the USB port 58 in response to a user operation of the operation device 55, thereby outputting the medicine distribution data. Input to the drug distribution support device 5.

The medication completion input unit 515 accepts a medication completion input operation for each user displayed on the resident list screen 211 (see FIG. 23) described later by the display device 54 or the mobile terminal 6. Specifically, the medication completion input unit 515 receives an input operation of the medication completion of the user to the operation device 55 or the mobile terminal 6.

The residual drug information output unit 516 can accept an operation of inputting residual drug information regarding a residual drug that the user did not take, and can output the residual drug information. Specifically, the remaining drug information output unit 516 receives an input operation of the remaining drug information to the operating device 55 or the mobile terminal 6. Then, the remaining drug information output unit 516 stores the remaining drug information in the data storage unit 52, and transmits and outputs the remaining drug information to the dispensing support device 1 via the network N1 and the network N2.

Further, in the drug distribution support device 5, the control unit 11 can register the information of the LTCF B and the resident as the initial setting information according to the user operation of the operation device 55 or the mobile terminal 6. Here, FIG. 16 is a diagram showing an example of a facility registration screen, and FIG. 17 is a diagram showing an example of a resident registration screen.

As shown in FIG. 16, the control unit 11 displays a facility registration screen for registering a facility code and a facility name in response to a user operation of the operation device 55. On the facility registration screen, after the facility code and the facility name are input, the registration key is operated, and the information is stored in the master storage unit 521 as the facility master. The facility code and the facility name are the same as the facility code and the facility name registered in the facility master (see FIG. 15) of the dispensing support device 1.

Further, as shown in FIG. 17, the control unit 11 displays a resident registration screen for registering resident information in response to a user operation of the operation device 55. Specifically, on the resident registration screen, it is possible to input a resident ID, a resident's name, a pseudonym, a date of birth, a gender, a management category, a group, a room code, a comment, and a face image (photograph). .. In the control category, for example, whether or not the drug is self-managed is selected. In the above management category, "Medication confirmation required", which requires confirmation of medication distribution and presence / absence of medication, and medications for a specified period of time are entrusted to the user, and medication distribution at the time of medication is not required, but medications are taken. "Medication confirmation required (self-management)" that requires confirmation of the presence or absence, and "Medication confirmation not required (self-management)" that the drug for a specified period is entrusted to the user and both distribution and confirmation of taking the drug are not required. ) ”And so on. Matters to be noted about the resident can be arbitrarily described in the comment, and the comment can be displayed on the resident confirmation screen 213 (see FIG. 25) described later. Further, as an input method for a face image (photograph), a capture input for selecting and capturing a photograph taken in advance from a list, and a camera 62 of the mobile terminal 6 are used when registering resident information. There is a shooting input to shoot. Then, on the resident registration screen, after the resident information is input, the information is stored in the master storage unit 521 as the resident master by operating the registration key. The resident ID, resident name (pseudonym), group, etc. included in the resident information are the resident ID registered in the resident master (see FIG. 15) of the dispensing support device 1, and the dose. Same as person name and group. Further, when the data key is operated on the resident registration screen, the control unit 11 executes import or export of resident information according to the subsequent operation.

Hereinafter, various processes executed in the drug distribution support system 100 configured in this way will be described. Also in the drug distribution support system 100, the drug packaging process (see FIG. 8), the storage time collation process (see FIG. 10), the delivery time collation process (see FIG. 11), and the receipt time process (see FIG. 11). (See FIG. 12) and the like are executed.

[Issuing process of prescription data]
First, with reference to FIG. 18, the prescription data issuance process executed by the drug distribution support system 100 will be described. Regarding the process of issuing the prescription data, the same processing procedure as that of the processing procedure described with reference to FIG. 5 is designated by the same reference numerals, and the description thereof will be omitted.

<Step S111>
As shown in FIG. 18, when the prescription data issuance operation is performed in the step S11, the control unit 11 executes the residual drug information input process for inputting the residual drug information in the subsequent step S111. .. Here, the step S111 is executed by the residual drug information input unit 115 of the control unit 11.

For example, in step S111, the control unit 11 requests the drug distribution support device 5 to transmit the remaining drug information via the network N1 and the network N2. Then, the control unit 11 receives the remaining drug information transmitted from the drug distribution support device 5 via the network N1 and the network N2. The remaining drug information is automatically transmitted from the drug distribution support device 5 at predetermined intervals or at predetermined timings via the network N1 and the network N2, and the remaining drug information input unit. It is also conceivable that 115 will acquire the residual drug information. Further, the drug distribution support device 5 may record the residual drug information on a recording medium such as the USB memory 19, and the dispensing support device 1 may read the residual drug information from the recording medium such as the USB memory 19. Conceivable. As a result, the remaining drug information can be utilized in the dispensing support device 1 without cooperation via the network N1 and the network N2.

<Step S112>
Next, in step S112, the control unit 11 notifies the information of the remaining drug that can be used as the prescription drug included in the prescription data based on the remaining drug information and the prescription data acquired in the step S111. do. Here, the step 112 is executed by the residual drug notification unit 116 of the control unit 11. Further, in step S112, the control unit 11 determines whether or not the prescription date in the prescription data is within the expiration date of the remaining drug included in the remaining drug information, and whether or not the prescription date is within the expiration date. It is also conceivable to display whether or not the display device 14 or the like.

For example, in step S112, the control unit 11 determines, based on the residual drug information and the prescription data, a drug that does not require packaging because it exists as a residual drug in the residual drug information among the prescription data. do. Then, the information of the medicine existing as the remaining medicine is displayed on the display device 14 or the like. As a result, a pharmacist or the like who refers to the display device 14 can easily recognize that the residual drug is available, and for example, by making a correction inquiry of the prescription data to a doctor, the drug can be used. It becomes possible to suppress waste. Specifically, it is conceivable that the number of days of administration or the number of times of administration may be adjusted after confirming the remaining drug information.

At this time, if the doctor excludes the medicine from the prescription data from the time when the medicine can be used or the medicine, it is premised that the medicine is used, so that the medicine is delivered to the LTCF B. There is a shortage of chemicals. Therefore, for example, when the package data is generated in step S12, the package data is generated so that the empty drug package 81 is issued even for the drug excluded from the package target due to the presence of the residual drug. It is conceivable. Specifically, in order to specify the time of administration and the remaining drug to be used at the time of taking the package data corresponding to the drug excluded from the target of package due to the presence of the remaining drug in the package data. It is conceivable that the residual drug specific information (for example, the time of administration) is included.

Then, in the drug packaging device 3, the time of taking the remaining drug and the information on specifying the remaining drug are printed on the empty drug package 81. For example, it is conceivable that a message such as "Please take the medicine after the XX day supper after the XX month XX day supper" is displayed on the empty medicine package 81. Thereby, in the LTCF B, it is possible to determine the remaining medicine to be used for each time of administration by referring to the empty medicine package 81. It is conceivable that the determination as to whether or not the remaining drug can be used is performed at each time of administration, that is, in units of the drug package 81. As a result, it is not necessary to take the medicine in the medicine package 81 together with the medicine remaining as the remaining medicine, and it is possible to suppress the occurrence of a medicine distribution error. Further, it is conceivable that information on the chemicals excluded from the packaging target is input by the operation input of the operating device 15 when the packaging data is generated. Further, when the control unit 11 of the dispensing support device 1 is modified by a doctor to use the residual drug, it is excluded from the packaging target based on the prescription data before and after the modification. It is also possible to determine when to take the drug.

<Step S14>
After that, in step S14, the control unit 11 waits for an output operation of the drug distribution data used on the LTCF B side (S14: No side). Specifically, the control unit 11 determines whether or not the drug distribution data output operation has been executed by a user operation on the operating device 15. Here, when it is determined that the output operation of the drug distribution data has been performed (S14: Yes side), the process proceeds to step S15.

<Step S15>
In step S15, the control unit 11 generates the drug distribution data based on the prescription data for which the issuing operation was performed in step S11, outputs the drug distribution data to the USB port 18, and the USB memory. Record at 19. That is, the control unit 11 outputs the drug distribution data in units such as the LTCF B or the group, which is the drug distribution group, similarly to the prescription data and the package data. As a result, the USB memory 19 is delivered to the drug distribution support device 5 together with the drug package 81, the drug bag 82, and the like, and the drug distribution data stored in the USB memory 19 is distributed to the drug distribution support device 5. It is possible to improve the efficiency of drug distribution work and suppress drug distribution mistakes by the person in charge of drug distribution. Further, since the drug distribution data is generated for the prescription data for which the issuing operation was performed in step S11, the time and effort for resetting the extraction conditions for generating the drug distribution data can be reduced. , It is prevented that the drug distribution data, which is the target of dispensing and is different from the prescription data, is generated.

The drug distribution data includes the resident ID, resident (taker) name, group, pseudonym, drug code (YJ code), drug name, date of administration, time of administration (usage), dose, dosage form, and package. It includes classification, side effect related information, and maximum daily dose (maximum number of times) of inoculation. Here, the one-pack category is a category for identifying drugs packaged in the same drug package 81. The side effect-related information includes information on side effects described in the package insert of the drug, or information on side effects arbitrarily registered in association with the drug in advance at the pharmacy A or the like. In the drug distribution support system 100, information such as a resident ID and a group managed by the drug distribution support device 5 is also registered in the resident master in the dispensing support device 1 on the pharmacy A side. .. Therefore, the control unit 11 can add information such as the resident ID and the group to the drug distribution data and output it with reference to the resident master. As a result, even when drugs are exchanged between the plurality of the pharmacy A and the plurality of LTCFs B, the drug distribution support device 5 can identify the resident based on the drug distribution data. It is possible. The drug distribution data includes the user ID, and the drug distribution support device 5 is based on the correspondence relationship (conversion information) between the user ID and the resident ID in each of the LTCF B. It is also conceivable as another embodiment to determine the resident corresponding to the user ID.

Here, FIG. 19 is a diagram showing an example of drug distribution data used in the LTCF B1. As shown in FIG. 19, the drug distribution data includes a resident ID, a resident (taker) name, a group, a dosage form, and a package classification in addition to the packaged data (see FIG. 6). It has been. Regarding the one-packing category, in the example shown in FIG. 19, both the drug M1 and the drug M3 of "Ichiro Yuyama" have the one-packing category "1" and are packaged in the same drug package 81. Is shown, and it is shown that the drug M7 and the drug M8 of "Yuyama Saburo" are packaged in different package 81 with "1" and "2" as one package category. Further, although omitted in FIG. 19, as described above, the drug distribution data also includes side effect-related information and the maximum daily dose (maximum number of times) of inoculation.

The USB memory 19 is an example of a recording medium used for moving the medicine distribution data, and various recording media such as another flash memory or a hard disk drive may be used instead of the USB memory 19. It is possible. Further, in the present embodiment, a configuration in which the drug distribution data can be moved using a recording medium such as the USB memory 19, will be described, but if the drug distribution data can be transmitted to the drug distribution support device 5. The method is not limited to this. For example, it is conceivable that the drug distribution data output unit 114 outputs the drug distribution data to the communication interface 13 and transmits the drug distribution data from the communication interface 13 to the drug distribution support device 5 through the network N1 such as the Internet. .. It should be noted that the drug distribution data output unit 114 may be configured to be able to transmit and output the prescription data corresponding to the drug distribution data to the drug distribution support device 5.

Further, the control unit 11 outputs the drug distribution data to a storage unit such as a server to which the dispensing support device 1 and the drug distribution support device 5 are communicably connected via the network N1 and the network N2 and the like. It is also possible to memorize it. That is, it is conceivable that the dispensing support device 1 and the drug distribution support device 5 share the drug distribution data on the cloud. As a result, the control unit 51 of the drug distribution support device 5 can read and input the drug distribution data from a storage unit such as the server. Further, in the drug packaging device 3, the drug package sheet in which the drug package 81 corresponding to each administration time is continuous is output for each user, and the drug package sheet is printed with information for drug inspection. When 81 is added, it is conceivable that a code such as a one-dimensional code or a two-dimensional code indicating the drug distribution data relating to the user is printed out on the drug package 81. As a result, in the drug distribution support device 5, the control unit 51 can input the drug distribution data for each user by reading the code from the drug package 81 for drug inspection. The code is not limited to the medicine package 81, and may be printed on a paper medium delivered together with the medicine package 81, for example. The drug distribution data included in the code also includes a dosing start time, which is the first dosing time in the current dosing data corresponding to the taking person, and a dosing end time indicating the last taking time. Further, instead of the drug distribution data, the prescription data corresponding to the user (for example, drug name, dosage, dose, dosing start date, dosing end date, etc.) is printed out on the drug package 81 for drug inspection. It is also possible that it is included in the above code.

Further, in the dispensing support device 1, when the package data is generated based on the prescription data premised on the use of the residual drug as described above, the control unit 11 takes the residual drug. It is conceivable to output the drug distribution data including the residual drug specific information indicating the relationship between the timing and the new administration timing. Then, in the drug distribution support device 5, when the control unit 51 reads the code 811 attached to the drug package 81 corresponding to the residual drug, the control unit 51 refers to the residual drug identification information. The time of administration corresponding to the medicine package 81 is recognized as a new time of administration. As a result, even when the remaining medicine is used, the medicine distribution support system 100 collates the dosing time and the resident corresponding to the medicine package 81, or manages whether or not the resident is taking the medicine. Is possible.

Here, the configuration in which the drug distribution data can be output at the timing when the package data is output in the prescription data issuance process shown in FIG. 18 has been described, but the control unit 11 outputs the drug distribution data. , It is also possible to output according to the operation of the operation device 15 at an arbitrary timing. Specifically, the control unit 11 waits for an operation of setting extraction conditions for extracting prescription data to be output from the prescription data stored in the prescription data storage unit 121. For example, in the dispensing support device 1, the control unit 11 displays a setting screen for setting the extraction conditions on the display device 14 in response to a setting start operation for the operation device 15. Then, the control unit 11 sets the extraction conditions according to the operation of the operation device 15 according to the setting screen. For example, one or more conditions of the facility code, the facility name, the group, the user ID, the user name, and the resident ID can be set. Here, if it is determined that the extraction conditions have been set, the control unit 11 generates the drug distribution data corresponding to the extraction conditions based on the prescription data stored in the prescription data storage unit 121.

Specifically, when the facility code is selected, from the prescription data stored in the prescription data storage unit 121, each of the users who are occupying the LTCF B corresponding to the facility code. Prescription data is extracted. When the group is selected as the extraction condition, the prescription data of each user belonging to the group is extracted from the prescription data stored in the prescription data storage unit 121. Then, the control unit 11 extracts a predetermined part or all of the prescription data as the drug distribution data. As a result, the amount of data can be reduced by omitting unnecessary information as the drug distribution data from the prescription data, or the prescription data can be used while minimizing the use of personal information of the user. Is possible. After that, the control unit 11 outputs the drug distribution data in the same manner as in step S15. As a result, the dispensing support device 1 can output the drug distribution data at any timing, not limited to the issuance timing of the prescription data.

[Collaboration processing at the time of drug distribution]
Next, with reference to the flowchart of FIG. 20, a drug distribution time collation process executed by the control unit 51 of the drug distribution support device 5 in the drug distribution support system 100 will be described.

<Step S81>
In step S81, the control unit 51 determines whether or not a predetermined drug distribution start operation has been performed on the operation device 55 or the mobile terminal 6. Here, if it is determined that the drug distribution start operation has been performed, the process proceeds to step S82, and if the drug distribution start operation has not been performed, the process proceeds to step S811.

By the way, in the drug distribution start operation, it is conceivable that a login operation of a drug distribution person such as a predetermined staff member is performed. In this case, it is conceivable that the data storage unit 52 is set with an identification code, a password, and the like for each person in charge of drug distribution. For example, after the drug distribution start operation is performed, the control unit 51 reads a code such as a one-dimensional code or a two-dimensional code written on a name tag or the like held by the person in charge of drug distribution by the reading terminal 7. If the information in the code matches the identification code of the person in charge of drug distribution, it is conceivable to log in the person in charge of drug distribution. Further, it is also conceivable that the control unit 51 logs in the drug distributor after collating the password when the password corresponding to the identification code is input after the identification code is read. Be done. As a result, the control unit 51 limits the information to be displayed in the drug distribution time matching process for each drug distribution person, or the resident to display in the drug delivery time matching process for each drug distribution person. It is possible to change the range of (for example, only the resident in charge of self).

<Steps S811 to S812>
In steps S811 to S812, an input process for inputting the drug distribution data output from the dispensing support device 1 is executed. Here, the steps S811 to S812 are executed by the drug distribution data input unit 514.

Specifically, first, in step S811, the control unit 51 waits for the input timing of the drug distribution data (S811: No side). For example, when the USB memory 19 is attached to the USB port 58 and a user operation is performed on the operating device 55, the control unit 51 determines that it is the input timing of the drug distribution data. Further, the control unit 51 also determines that it is the input timing of the drug distribution data even when the drug distribution data is received by the communication interface 53 via the network N2 or the like. Then, when it is determined that the input timing of the drug distribution data has arrived (S811: Yes side), the process proceeds to step S812.

In step S812, the control unit 51 inputs the drug distribution data to the dispensing support device 1. For example, the control unit 51 stores information necessary for executing the drug distribution time collation process in the drug distribution data storage unit 523 according to a predetermined database format. As a result, the drug distribution support device 5 can execute various processes using the drug distribution data used at the time of dispensing in the dispensing support device 1.

<Step S82>
On the other hand, if it is determined in step S81 that a predetermined drug distribution start operation has been performed on the operation device 55 or the mobile terminal 6, in the subsequent step S82, the person in charge of drug distribution may use the control unit 51. The initial screen 210 (an example of the first display screen) to be referred to at the time of drug distribution is displayed. Specifically, the control unit 51 causes the display device 54 to display the initial screen 210 when the drug distribution start operation is performed by the operation device 55. Further, when the medicine distribution start operation is performed by the mobile terminal 6, the control unit 51 causes the display unit of the mobile terminal 6 to display the initial screen 210. Similarly, in the subsequent processing, the operation by the operation device 55 is reflected in the display of the display device 54, and the operation in the mobile terminal 6 is reflected in the display of the display unit of the mobile terminal 6.

Here, FIG. 21 is an example of the initial screen 210. As shown in FIG. 21, the control unit 51 displays a selection key for selecting an administration time to be taken from now on based on the drug distribution data. Specifically, in the example shown in FIG. 21, the control unit 51 displays the dosing time corresponding to today on the initial screen 210 as a selection candidate. On the initial screen 210, "before", "after", and "between" are displayed in a tree for each of breakfast, lunch, and dinner, so that the person in charge of drug distribution can easily find the desired dosing time. In addition, a configuration in which the dosing date and time can be selected in the front stage of the initial screen 210 is also conceivable as another embodiment.

Further, as shown in FIG. 21, the control unit 51 displays on the initial screen 210 the time of administration in which the drug to be taken exists and the time of administration in which the drug to be taken does not exist in different display modes. This makes it possible for the person in charge of drug distribution to easily determine the presence or absence of a drug to be taken at each time of administration. It should be noted that the difference in the background pattern at the time of administration in FIG. 21 indicates that there is a difference in the display mode. For example, the time of administration in which the medicine to be taken exists (after dinner, between dinners, etc. in FIG. 21) is highlighted, and the time of administration in which the medicine to be taken does not exist (before breakfast, after breakfast, between breakfast, etc. in FIG. 21) is highlighted. ) May not be highlighted. It is also possible that the display color of the time of administration in which the drug to be taken is present and the display color of the time of administration in which the drug to be taken does not exist are different. Further, it is conceivable that the display size of the time of administration in which the medicine to be taken is present is large, and the display size of the time of administration in which the medicine to be taken does not exist is small.

Further, as shown in FIG. 21, it is conceivable that the control unit 51 displays the dosing time closest to the current time on the initial screen 210 in a display mode different from other dosing times. As a result, it is possible to suppress mistakes in selecting the time of administration by the person in charge of drug distribution, and to reduce the trouble of searching for the time of administration to be selected. In order to realize such display processing, in the drug distribution support device 5, in the data storage unit 52, the dose time name, the dose time, the dose time code, the dose classification, etc. corresponding to each dose time are taken. Time information is stored in advance. Thereby, the control unit 51 can determine the dosing time to be taken at the present time based on the taking time information. The dosing time code is information indicating the same content as the taking time code printed on the medicine package 81, and is unified information commonly used in the dispensing support device 1 and the medicine distribution support device 5. .. The control unit 51 can change the dosing time information according to the user operation in the initial setting of the drug distribution support device 5.

By the way, in FIG. 21, the initial screen 210 in which the dosing time is displayed in a tree is shown, but as another example of the initial screen 210 for selecting the dosing time, for example, as shown in FIG. 22, each taking time is shown. May be displayed individually in an array. Further, the control unit 51 can arbitrarily set the display position, display size, and display color of each of the administration times on the initial screen 210 in advance according to the operation of the operation device 55 or the mobile terminal 6. Can be considered. Further, it is conceivable that the control unit 51 can arbitrarily set the type of the dosing time displayed on the initial screen 210 according to the operation of the operating device 55 or the mobile terminal 6. Thereby, for example, the user can arbitrarily customize the initial screen 210 to have a screen configuration that is easy for him / her to see, or eliminate the display of unnecessary information on the initial screen 210.

Further, in the LTCF B, it is conceivable that medicines are brought in not only from the specific pharmacy A but also from other pharmacies, and the distribution of the medicines is managed. Therefore, in the drug distribution support device 5, the control unit 51 can also synthesize the drug distribution data acquired from the plurality of the pharmacy A. Further, in the drug distribution support device 5, it is conceivable that the control unit 51 can arbitrarily input the drug distribution data according to the operation of the operation device 55 or the mobile terminal 6. Specifically, the control unit 51 is for registering information such as a resident, a medical institution, a doctor, a usage (dose time), a type of medicine, a dose, and a comment according to the operation of the operation device 55. The registration screen is displayed, and the information entered in the registration screen is entered as the drug distribution data.

<Step S83>
Then, in step S83, the control unit 51 waits for the selection of the dosing time to be taken (S83: No side). Here, when it is determined that the dosing time has been selected (S83: Yes side), the process proceeds to step S84.

Specifically, the control unit 51 determines that the dosing time has been selected when the operation for selecting the dosing time on the initial screen 210 is performed by the operating device 55 or the operating unit of the mobile terminal 6. .. Further, the control unit 51 may use the mobile terminal 6 or the reading terminal 7 to use a one-dimensional code or a one-dimensional code indicating the dosing time, which is previously attached to the medicine distribution box containing the medicine package 81 corresponding to each taking time. When a code such as a two-dimensional code is read, it may be determined that the time of administration has been selected.

By the way, the medicine distribution support system 100 includes an automatic storage device that automatically stores medicines such as the medicine package 81 corresponding to each administration time of a plurality of users in the medicine distribution box corresponding to each administration time. The configuration is also conceivable. As a result, the medicines prescribed to a plurality of users are automatically stored in the medicine distribution box at each time of administration, so that the medicine package 81 is placed in the medicine distribution box at the pharmacy A or the LTCF B. The trouble of accommodating in is saved. The automatic accommodating device may be mounted on the chemical packaging device 3. By the way, the medicine distribution box is, for example, a box provided with a plurality of partitioned storage portions, but may be a so-called blister pack. The blister pack is an accommodating member in which a plurality of closed packaging portions are formed by joining a packaging member having a plurality of packaging areas having an open surface to a flat plate-shaped member. Further, in the blister pack, a cut dotted line (perforation) for easily separating each of the packaging portions is formed.

Here, the control unit 51 determines whether or not the dosing time selected in step S83 is an appropriate dosing time corresponding to the current date and time measured by the drug distribution support device 5, and is not appropriate. In some cases, it is possible to notify that fact. Specifically, in the drug distribution support device 5, a dosing time or a dosing time zone corresponding to each dosing time is set in advance and stored in the data storage unit 52. For example, the dosing time corresponding to the dosing time "after lunch" is set to "13:00", the dosing time corresponding to the taking time "between lunch" is set to "15:00", and the dosing time corresponds to "before dinner". It is conceivable that the dosing time zone is set to "18:00". In this case, the control unit 51 determines whether or not the current time is within a predetermined allowable range such as 30 minutes before and after the dosing time corresponding to the dosing time selected in step S83. Can be considered. As the current time, for example, a time measured as a system clock of the drug distribution support device 5 or a time that can be acquired from a predetermined time notification organization via the network N2 or the like is used. In addition, the dosing time zone corresponding to the dosing time "after lunch" is set to "12:30 to 13:00", and the dosing time zone corresponding to the dosing time "between lunch" is set to "15:00 to 16:00". Therefore, it is conceivable that the dosing time zone corresponding to the dosing time "before dinner" is set to "18:30 to 19:00". In this case, the control unit 51 may determine whether or not the current time is the dosing time zone corresponding to the dosing time selected in step S83.

Further, the control unit 51 determines the dosing time selected on the initial screen 210 and the one-dimensional code or two-dimensional code attached to the medicine distribution box read by the mobile terminal 6 or the reading terminal 7. It is possible to collate with the time when the code was taken, and if the collation results do not match, it is possible to notify that fact. In this case, in the drug distribution support device 5, the control unit 51 is one-dimensional including information to be affixed to the drug distribution box such as, for example, the date and time of administration, the timing of administration, and a group in response to the operation of the operation device 55. It is conceivable that a code such as a code or a two-dimensional code can be printed on a label or the like by an arbitrary printer. Further, the dosing date and time selected by the control unit 51 before the display of the initial screen 210, and the dosing date and time of the code attached to the medicine distribution box read by the mobile terminal 6 or the reading terminal 7. Can be collated, and if the collation results do not match, a configuration capable of notifying that fact is also conceivable. Similarly, the control unit 51 can collate the group displayed on the initial screen 210 with the group of the code attached to the medicine distribution box read by the mobile terminal 6 or the reading terminal 7. , If the collation results do not match, it is possible to notify that fact.

<Step S84>
In step S84, the control unit 51 causes the display device 54 or the display unit of the mobile terminal 6 to display the resident list screen 211 (an example of the second display screen) on which the list of residents is displayed. Here, FIG. 23 is a diagram showing an example of the resident list screen 211. Specifically, the control unit 51 has the resident list screen based on the resident master stored in the master storage unit 521 and the drug distribution data stored in the drug distribution data storage unit 523. Display 211.

In particular, as shown in FIG. 23, the control unit 51 includes a resident who has a drug to be taken at the time of administration determined to be selected in step S83 on the resident list screen 211, and a resident who takes the drug at the time of administration. Residents who do not have the chemicals to be used are displayed in a different display mode. That is, the control unit 51 can display the relationship between each of the residents and each of the dosing times by executing the steps S81 to S84. Here, the display process is executed by the display control unit 511, and the display control unit 511 is an example of the prescription display means. In particular, the display control unit 511 when displaying the initial screen 210 for selecting the dosing time in steps S81 to S82 is an example of the first display processing means, and the initial screen in steps S83 to S84. The display control unit 511 when displaying the resident list screen 211 that displays the necessity of distribution of each of the resident at the time of taking the medicine according to the selection of the time of taking the medicine in 210 is the second display processing means. This is just one example.

Thereby, the person in charge of drug distribution can easily determine the resident in which the medicine to be taken exists at each time of administration by using the initial screen 210 and the resident list screen 211. The difference in the background pattern of the resident in FIG. 23 indicates that there is a difference in the display mode. For example, a resident who has a drug to be taken (such as "Ichiro Yuyama") may be highlighted, and a resident who does not have a drug to be taken (such as "Saburo Yuyama") may not be highlighted. It is also possible that the display color of the resident who has the medicine to be taken is different from the display color of the resident who does not have the medicine to be taken. Further, it is conceivable that the display size of the resident who has the medicine to be taken is large and the display size of the resident who does not have the medicine to be taken is small.

Further, on the resident list screen 211, as status information regarding the medication status of the resident, in addition to the presence or absence of the medicine to be taken at the time of taking the medicine, "not taken", "taken", and "going out". , "Not taken", "No self-management confirmation", "Self-management unconfirmed", "Self-management confirmed", "At work", "Cannot take medication", "In hospital" etc. may be displayed. Conceivable. That is, on the resident list screen 211, these plurality of status information can be displayed in different display modes such as different color schemes or display sizes.

For example, in the example shown in FIG. 23, "Hachiro Yuyama" is displayed in a display mode corresponding to "dose completed", and residents such as "Kuro Yuyama" are displayed in a display mode corresponding to "not yet taken". ing. This makes it possible for the person in charge of drug distribution to easily determine whether or not the drug should be distributed at the selected dosing time for each resident. Further, in the example shown in FIG. 23, "Yuyama Nanata" is displayed in a display mode corresponding to "going out", and the person in charge of drug distribution indicates that "Yuyama Nanata" is out of the office or staying overnight. It is possible to easily determine that no drug distribution is required. Here, the status information such as whether or not each resident has gone out is obtained in advance by the control unit 51 according to the operation of the operation device 55 or the operation unit of the mobile terminal 6 by the resident of the master storage unit 521. It may be remembered as part of the master.

In addition, "during work" indicates that the resident is out of work, "impossible to take medication" indicates that the resident is in a state of health that is difficult to take, and "during hospitalization" indicates that the resident is in the above-mentioned occupancy. Indicates that the person is in the hospital. In addition, "not yet taken" indicates that the user has not taken the drug, but the drug has been treated as a residual drug and the drug has been taken. Further, "no self-management confirmation" indicates that it is not necessary to confirm the presence or absence of the drug in the case where the drug is deposited in advance with the user for a predetermined period and the user is self-managed. On the other hand, "self-management unconfirmed" and "self-management confirmed" indicate that the user is self-managed by depositing the drug for a predetermined period in advance, but it is necessary to confirm the presence or absence of the drug. "Unconfirmed management" indicates that the medication has not been confirmed yet, and "Self-management confirmed" indicates that the medication has already been confirmed and an input operation to that effect has been performed.

In the resident list screen 211 shown in FIG. 23, the occupants who are not displayed on the same screen can be displayed by scrolling, and the resident display order on the resident list screen 211 is, for example, in alphabetical order or alphabetical order. be. Further, the control unit 51 displays the resident display on the resident list screen 211 according to the selection of the operation key of "all" on the resident list screen 211, and only the occupants who have not taken the drug are displayed. It is possible to switch between the status and the status in which all the residents are displayed. Further, the control unit 51 changes the status information of the resident displayed on the resident list screen 211 to the state of "not yet taken" in response to the selection of the "complete" operation key on the resident list screen 211. It is conceivable to change and store the untaken drug (medicine package 81) corresponding to the time of administration in the data storage unit 52 as the remaining drug information. Further, when the control unit 51 stores and stores the remaining drug information in the data storage unit 52, the state of the tablet contained in the medicine package 81 is stored without calculating the total of the remaining drug information. Store as it is. For example, when one tablet and 0.5 tablet (half tablet) of a drug for a certain resident are packaged in a drug package 81 and the drug package 81 remains for three times, the data storage unit 52 may use the drug package 81. , Information of 1.5 tablets × 3 instead of 4.5 tablets is stored as the residual drug information.

By the way, in the drug distribution support system 100, as shown in the resident master (see FIG. 15) and the resident registration screen (see FIG. 17), the resident can be classified into a plurality of groups. be. In this case, another embodiment may be considered in which the control unit 51 displays the resident list screen 211 for each group. Here, FIG. 24 is a diagram showing an example of the resident list screen 211 in the case where each of the occupants is displayed for each group.

On the resident list screen 211 shown in FIG. 24, tabs corresponding to each group are displayed, and when the tab is selected, a list of occupants belonging to the group of the tab is displayed. In this case as well, the display mode of the resident shown in FIG. 23 is the same as that of the resident list screen 211, so the description thereof will be omitted. Further, as described above, when the code attached to the medicine distribution box contains information indicating the group, the control unit 51 is the code indicated by the code read by the mobile terminal 6 or the reading terminal 7. It is conceivable to display the resident list screen 211 corresponding to the group. Further, the control unit 51 has a group of the tabs selected on the resident list screen 211 in FIG. 24 and a group indicated by the code read from the medicine distribution box by the mobile terminal 6 or the reading terminal 7. It is possible to collate whether or not they match, and if the collation results do not match, it is possible to notify that fact.

<Step S85>
Next, in step S85, the control unit 51 waits for the selection of the resident to be taken (S85: No side). Here, if it is determined that the resident has been selected (S85: Yes side), the process proceeds to step S86.

Specifically, the control unit 51 is said to have selected a resident when the operation for selecting a resident on the resident list screen 211 is performed by the operation device 55 or the operation unit of the mobile terminal 6. to decide. Further, the control unit 51 has a code such as a name tag, a wristband, or a one-dimensional code or a two-dimensional code attached to the medicine package 81, for example, by the mobile terminal 6 or the reading terminal 7. When it is read, it may be determined that the resident corresponding to the resident ID indicated by the code has been selected. Further, the control unit 51 can collate the resident selected on the resident list screen 211 with the resident indicated by the code read by the mobile terminal 6 or the reading terminal 7, and the collation result. It is also conceivable to have a configuration in which it is possible to notify that fact when there is a discrepancy.

In step S85, when the menu key on the resident list screen 211 is operated, the control unit 51 performs the drug distribution start operation to display the display device 54 or the mobile terminal 6. Return to the previous menu screen, etc. Further, when the return key is operated, the control unit 51 returns the display of the display device 54 or the mobile terminal 6 to the initial screen 210.

<Step S86>
In step S86, the control unit 51 causes the display device 54 or the display unit of the mobile terminal 6 to display a resident confirmation screen 213 for confirming the resident determined to be selected in step S85. Specifically, the control unit 51 displays resident information, medication information, and the like based on the resident master and the drug distribution data stored in the master storage unit 521 on the resident confirmation screen 213. To display. Here, FIG. 25 is a diagram showing an example of the resident confirmation screen 213.

As shown in FIG. 25, on the resident confirmation screen 213, the resident's name, face image (photograph), and comment are displayed as resident information. Further, on the resident confirmation screen 213, usage and drug information among the drug distribution data are displayed. As a result, the person in charge of drug distribution can easily grasp the suitability of the resident and the drug to be distributed. In addition, a confirmation key, a cancellation key, and a non-dose key are displayed on the resident confirmation screen 213. The confirmation key is an operation key for inputting that the resident has confirmed that it is appropriate. The cancel key is an operation key for canceling the selection of the resident and returning the display of the display unit of the display device 54 or the mobile terminal 6 to the resident list screen 211. The non-dose key is an operation key for inputting the reason for not taking the drug when the resident did not take the drug and completing the drug without taking the drug. If the drug distribution confirmation data is a part or all of the prescription data itself, it is possible that the content of the drug after the actual dispensing (for example, the state of packaging) cannot be grasped. In this case. It is conceivable that the control unit 51 may omit the display of the drug information on the resident confirmation screen 213.

Further, the data storage unit 52 stores a drug master or the like including the side effect-related information regarding side effects to be noted for each drug, and the resident confirmation screen 213 shows the side effect-related of the drug taken by the resident. Information may be displayed. Further, the control unit 51 may access the dispensing support device 1 through the network N1 and display the side effect-related information of the drug with reference to the drug master stored in the dispensing support device 1. Conceivable. As a result, the person in charge of drug distribution can easily grasp the matters to be noted about the state of the resident by referring to the side effect-related information when the drug is distributed to the resident, for example, the abnormality of the resident. It becomes possible to detect such things at an early stage. Further, on the resident confirmation screen 213, as information for identifying the dosing time, it is conceivable that the taking time code is displayed in place of the character indicating the taking time or together with the taking time. As a result, the person in charge of drug distribution can easily confirm the time of administration by referring to the time code of administration when the time code of administration is printed on the medicine package 81. Further, on the resident confirmation screen 213, the status information (“not taken”, “taken”, “going out”, “completed taking”, “no self-management confirmation”, “self-management” regarding the taking of the resident "Unconfirmed", "Self-management confirmed", "At work", "Cannot take medication", or "In hospital") may be displayed. When the chemical master includes chemical image data such as a photograph of each chemical, the control unit 51 can also display the chemical image data on the resident confirmation screen 213.

<Step S87>
Subsequently, in step S87, the control unit 51 waits for a confirmation operation (S87: No side). Here, if it is determined that the confirmation operation has been performed, the process proceeds to step S871, and if the confirmation operation has not been performed, the process proceeds to step S88.

Specifically, the control unit 51 determines that the confirmation operation has been performed when the confirmation key on the resident confirmation screen 213 is operated. At this time, the control unit 51 displays an input screen for inputting a resident ID in response to the operation of the confirmation key, and displays the resident ID input on the input screen on the resident confirmation screen 213. It is also conceivable to collate with the resident ID corresponding to the resident who has been set up, and if the collation results do not match, it is possible to notify that fact. For example, when the collation results do not match, the control unit 51 returns the display screen to the resident list screen 211 after displaying an error message on the display device 54 or the mobile terminal 6.

Further, the control unit 51 displays an input screen for inputting a resident ID according to the operation of the confirmation key before displaying the resident confirmation screen 213 in the step S86, and on the input screen. It is also conceivable to collate the input resident ID with the resident ID corresponding to the resident selected in step S85. In this case, if the collation results match, the control unit 51 shifts the process to the step S86 to display the resident confirmation screen 213, and if the collation results do not match, notifies that fact. Can be considered. Similarly, in the configuration in which the control unit 51 collates the resident selected on the resident list screen 211 with the resident indicated by the code read by the mobile terminal 6 or the reading terminal 7. It is conceivable to display the resident confirmation screen 213 after it is confirmed that the collation results match.

Further, in the control unit 51, the code 811 attached to the medicine package 81 is read by the mobile terminal 6 or the reading terminal 7, and the resident indicated by the code 811 is displayed on the resident confirmation screen 213. It is also conceivable that it is determined that the confirmation operation has been performed when the resident matches the resident. If the occupants do not match, the control unit 51 returns the display screen to the resident list screen 211 after displaying an error message on the display device 54 or the mobile terminal 6. By the way, in order to thoroughly confirm the reading of the medicine package 81 by the mobile terminal 6 or the reading terminal 7, it is conceivable as another embodiment to omit the display of the confirmation key on the resident confirmation screen 213.

<Step S871>
In step S871, the control unit 51 causes the display device 54 or the mobile terminal 6 to display a message urging the resident to start dosing. Then, the person in charge of drug distribution distributes the drug package 81 to the resident. It is also conceivable that the resident confirmation screen 213 displays information on whether or not the resident is self-managed as a management category. As a result, the person in charge of drug distribution can easily determine the management classification of the resident when the drug package 81 is distributed.

<Step S872>
Further, in step S872, the control unit 51 associates the drug distribution data stored in the drug distribution data storage unit 523 with the drug distribution result displayed on the resident confirmation screen 213 to the resident. "Completion of medication" is recorded, and the process is returned to step S81. As a result, when the resident list screen 211 is displayed next, the resident's name is displayed in a display mode indicating that the medication is not required for the time when the medication has already been taken. Here, in steps S87, S871 and S872, the process of accepting the confirmation operation as an input operation for the completion of medication for each resident is executed by the medication completion input unit 515. It is also conceivable that step S87 may be omitted. That is, when the code attached to the medicine package 81 is read and a resident is selected (S85: Yes side), the resident confirmation screen 213 is displayed and identified by the code (S86). It is also conceivable that the completion of taking the medicine package 81 of the resident at the time of taking the medicine package 81 is automatically recorded (S872).

<Step S88>
Further, in step S88, the control unit 51 waits for the operation of the unadministered key (S88: No side). Here, if it is determined that the unadministered key has been operated, the process proceeds to step S881, and if the unadministered key has not been operated, the process proceeds to step S89. It is also conceivable that the control unit 51 may display a confirmation message such as "Is it okay to take no dose?" When the not-taken key is operated.

<Step S881>
In step S881, as shown in FIG. 26, the control unit 51 pops up a non-medication input screen 214 for inputting the reason why the resident did not take the drug on the resident confirmation screen 213. After displaying in, the reason for not taking the medicine input in the input for not taking the medicine is stored in association with the medicine distribution data stored in the medicine distribution data storage unit 523. For example, as shown in FIG. 26, the input of the reason for not taking the drug is performed by displaying a list of the reasons for not taking the drug registered in advance and selecting the reason for not taking the drug. Here, it is also conceivable that the reason for not taking the drug can be input by selecting from a plurality of predetermined candidates displayed in a pull-down format. The reason for not taking the drug may be, for example, going out, going to bed, or refusing to take the drug. In addition, the control unit 51 associates with the drug distribution data stored in the drug distribution data storage unit 523, and as a result of drug distribution to the resident displayed on the resident confirmation screen 213, "not yet taken medicine". Record "completion". As a result, when the resident list screen 211 is displayed next, the resident's name is displayed in a display mode indicating that the medication is not required for the time of administration in which the reason for not taking the medication has already been entered. Will be done.

By the way, it is possible that the resident has a predetermined plan to go out (work, staying out, hospitalization, etc.). Therefore, it is conceivable that the drug distribution support device 5 can input the schedule of the resident who has not yet taken the drug. Specifically, FIG. 27 is a diagram showing an example of a schedule input screen 215 for inputting a schedule of untreated medication of a resident. As shown in FIG. 27, on the schedule input screen 215, an arbitrary schedule is selected by the operation of the operation device 55 or the mobile terminal 6, a pre-registered dosing time is selected, and the reason for not taking the drug is Entered. Note that FIG. 27 shows a state in which March 12 to 14, 2014 is selected on the schedule input screen 215. When the schedule for non-medication is input in this way, the control unit 51 omits the input processing of the reason for non-medication in step S881 when the non-medication key is operated (S88: Yes side). Then, it is conceivable to display the information of the scheduled untaken schedule that has already been registered. Further, when the schedule of non-dose is input, the control unit 51 omits the confirmation work of the resident by displaying that the non-dose is completed on the resident list screen 211. It is also possible to make it.

<Step S882>
Then, in step S882, the control unit 51 determines that the resident should have taken the medicine as the remaining medicine information regarding the remaining medicine that the resident did not take, which is displayed on the resident confirmation screen 213. The information is output together with the resident information (drug distribution data, etc.). Here, the processing is executed by the residual drug information output unit 516.

Specifically, in step S882, the control unit 51 outputs the residual drug information to the communication interface 53, and transmits and outputs the residual drug information from the communication interface 53 to the dispensing support device 1 through the network N2 such as the Internet. Can be considered. Further, the method is not limited to this as long as the remaining drug information can be transmitted to the dispensing support device 1, and for example, the control unit 51 may record and output to the USB memory 19 via the USB port 58. Conceivable. As a result, in the dispensing support device 1, a doctor, a pharmacist, or the like can refer to the remaining drug information when prescribing the next drug, and for example, waste of the prescribed drug can be prevented. The residual drug information is also stored in the data storage unit 52. This makes it possible to refer to the remaining drug information also in the drug distribution support device 5 or the mobile terminal 6.

<Step S89>
In step S89, the control unit 51 waits for the operation of the cancel key (S89: No side). Here, when it is determined that the cancel key has been operated (S89: Yes side), the process proceeds to step S84 and the resident list screen 211 is redisplayed. If the cancel key is not operated (S89: No side), the process proceeds to step S87.

As described above, in the drug distribution support system 100, the drug distribution support device 1 executes the drug distribution support device 5 by providing the drug distribution support device 1 to the drug distribution support device 5. It is possible to realize display and operation in consideration of the drug distribution data in the drug distribution collation process and the like. As a result, it becomes possible to efficiently execute the drug distribution work to the resident by the drug distributor, and it is possible to suppress the drug distribution error of the drug distributor.

[Other features]
In the drug distribution support system 100, the following other functions can be realized by providing the drug distribution data to the drug distribution support device 5.

[Side effect information input function]
For example, it is conceivable that the control unit 51 can arbitrarily input the health state or side effect state of the resident to the resident confirmation screen 213. In this case, it is conceivable that the control unit 51 can input a plurality of predetermined items in a pull-down format in consideration of the display space of the resident confirmation screen 213. In particular, the control unit 51 may narrow down and display side effect candidates corresponding to the medicines taken by the resident based on the side effect-related information and the drug distribution data. As a result, on the LTCF B side, it is possible to easily input the side effect by selecting from the candidates. Further, the control unit 51 displays an input start key such as the health state or side effect state of the resident on the resident confirmation screen 213, and responds to the operation of the input start key from the resident confirmation screen 213. It is also conceivable to display the side effect information input screen 216 in a pop-up. Here, FIG. 28 is a diagram showing an example of the side effect information input screen 216. Further, as shown in FIG. 29, when a predetermined operation for inputting side effect information is performed on a menu screen other than the resident confirmation screen 213, the control unit 51 has a resident name and a photograph. , Side effect information, comment, etc. are displayed on the resident status screen 217, and when the side effect information input operation on the resident status screen 217 is performed, the side effect information input screen 216 is displayed in a pop-up. Is also possible. The side effect information input screen 216 is also used to input arbitrary comment information in advance for each resident.

Then, when the side effect information regarding the health state or the side effect state of the resident is input on the side effect information input screen 216, the control unit 51 stores the side effect information in the data storage unit 52. , It is conceivable to transmit to the dispensing support device 1 by the communication interface 53. The side effect information is recorded in a recording medium such as the USB memory 19, and the USB memory 19 is connected to the dispensing support device 1 or the higher-level system (not shown), whereby the dispensing support device 1 or the said. It is also conceivable that the side effect information is input to a host system (not shown) or the like. According to these configurations, for example, when a doctor examines the resident, side effect information such as the health state or the side effect state of the resident is referred to by the drug distribution support device 5 or the mobile terminal 6. Is possible.

It is also conceivable that the control unit 51 can identify and display a suspected drug that is likely to cause a side effect that is occurring based on the side effect information and the side effect-related information. Here, when the drug master contains drug image data such as a photograph of each drug, the control unit 51 displays the drug image data of the suspected drug on the resident confirmation screen 213. Is also possible. As a result, for example, a human error in extracting the suspected drug from the drug package 81 in which a plurality of drugs are packaged is suppressed.

Further, by transmitting the information to the dispensing support device 1, the pharmacy side can easily grasp the information such as the health state or the side effect state of the resident. In particular, in the dispensing support device 1, it is considered that the side effect information can be transmitted to the higher-level system (not shown) by the control unit 11. As a result, the doctor who prescribes the resident's medicine can also refer to the side effect information in the higher system (not shown), and the hospital (doctor), the pharmacy (pharmacist), and the health care facility (in charge of drug distribution). A medical system in which people) are closely linked is realized.

Further, since the side effect information can be referred to by the dispensing support device 1 or the higher-level system (not shown), for example, when dispensing based on the next prescription data of the resident, the pharmacist can use the side effect information. Based on this, it is possible to omit the dispensing of specific chemicals. Further, in the dispensing support device 1, the control unit 11 may automatically exclude the drug subject to the side effect information from the dispensing target and generate the packaging data or the like. When the side effect information includes the date and time when the administration was stopped due to the occurrence of the side effect, the amount of the drug not taken, and the like, the control unit 11 in the dispensing support device 1 displays the side effect information. It is also conceivable to specify the unadministered drug and the remaining amount based on the above, and to generate the packaged data by removing the remaining amount from the prescribed amount of the unadministered drug at the time of the next generation of the packaged data. The pharmacist on the pharmacy A side refers to the side effect information displayed on the dispensing support device 1, informs the doctor of the suspected drug that may be the cause of the side effect, and inputs a new prescription. At times, it is possible to prompt for prescription input excluding the suspected drug, or to prompt amendment (reissue) excluding the suspected drug from the entered prescription. In addition, contact the doctor about the amount of untaken medicine and prompt the doctor to input the prescription excluding the amount of the untaken medicine when inputting a new prescription, or correct the prescription to be removed from the entered prescription (the amount of the untaken medicine is excluded). It is also possible to encourage reissue).

[Pharmaceutical distribution box opening / closing function]
Further, a medicine distribution box having a storage unit for accommodating the medicine package 81 corresponding to each time of administration and capable of opening / closing control for each storage unit is used by being communicably connected to the medicine distribution support device 5. Can be considered. In this case, the control unit 51 controls the opening and closing of each of the storage units in the medicine distribution box so that the medicine corresponding to the time of administration cannot be taken out until the time of administration arrives, based on the medicine distribution data. It is conceivable to do. As a result, it is possible to suppress a drug distribution error for the resident.

[Medication history display function]
Further, it is considered that the control unit 51 has a medication history display function for displaying the history of the medication distribution data and the medication result stored in the medication distribution data storage unit 523. Here, FIGS. 30 to 33 are diagrams showing an example of a history screen that can be displayed by the medication history display function.

First, the control unit 51 displays the history screen 218 shown in FIG. 30 when a predetermined operation for displaying the medication history is performed while the menu screen is displayed on the display device 54 or the like. On the history screen 218, the medication results of each resident are displayed on a daily basis. In the history screen 218, the “◯” mark indicates that the drug has been taken, the “Δ” mark indicates that the drug has not been taken, and the “×” mark indicates that the drug has not been taken. The "partially untreated drug" refers to a state in which the drug is taken and the drug is not taken at a plurality of times of administration included in one day. For example, when the above-mentioned partially untreated drug includes three times of administration in the morning, noon, and evening, one or two of the morning, noon, and evening are not taken. Is the case. Further, on the history screen 218, the background color or shape of the mark corresponding to the day on which the information such as the information on the remaining medicine or the information on the side effect excluding the information on the presence or absence of medication is recorded is different from the usual background color or Displayed in shape.

By the way, when the drug distribution data or the prescription data including the administration start date, administration end date, administration time (before breakfast, after lunch, etc.) and the like are input to the drug distribution support device 5, the control unit 51 Is conceivable to display the necessity schedule of administration corresponding to each patient on the history screen 218. As described above, the drug distribution data or the prescription data is input from, for example, the dispensing support device 1, read from the USB memory 19, or read from the medicine package 81. Specifically, the control unit 51 may display a predetermined diamond-shaped mark or the like in the column corresponding to the date when the drug needs to be taken to indicate that the drug needs to be taken. In addition, when a schedule that does not need to be taken, such as a resident's outing schedule or a sleepover schedule, is input first on the history screen 218, the control unit 51 will display the schedule on the history screen 218. It is conceivable to display a predetermined "outside" mark or the like in the column corresponding to the scheduled date to indicate that the patient does not need to take the drug.

Then, when an operation for selecting a resident is performed on the history screen 218, the control unit 51 displays the history screen 219 shown in FIG. 31 in place of the history screen 218. On the history screen 219 shown in FIG. 31, the history of each drug taken by the selected resident is displayed on a daily basis. Further, in the history screen 219, a display column for "other information" is provided at the bottom, and in the display column, "○" is recorded on the day when information such as residual drug information or side effect information is recorded. Is described. Then, when the area where "○" is described is selected from the display column of "other information", the control unit 51 places the operation pointer of the operation device 55 or the mobile terminal 6 in the area. If it exists, it is conceivable to display information such as residual drug information or side effect information corresponding to the display column in a pop-up.

Further, when a date is selected on the history screen 219, the control unit 51 displays the history screen 220 shown in FIG. 32 instead of the history screen 219. On the history screen 220 shown in FIG. 32, the history of each drug taken by the selected resident is displayed in units of time of administration. The history screen 220 also displays a display column for "other information" as in the history screen 219.

When a place where information on the remaining medicine is recorded is selected in the display column of "Other information" on the history screen 219 or the history screen 220, the control unit 51 displays the information on the remaining medicine. It is conceivable to read from the drug distribution data storage unit 523 and display it on the history screen 221 shown in FIG. 33. In the history screen 221 shown in FIG. 33, "2 tablets" is shown as the remaining drug status of the drug M1, and "1.5 tablets x 3" is shown as the remaining drug status of the drug M2. Here, it is conceivable that the remaining drug status of the drug M2 is displayed as "4.5 tablets", which is the calculation result of 1.5 tablets x 3, but the control unit 51 displays the dosage form of the drug M2. In consideration, it is displayed as "1.5 tablets x 3". As a result, it is clarified that the remaining drug of the drug M2 is not a total of 5 tablets of 4 tablets and 0.5 tablets, but a total of 6 tablets of 1 tablet and 0.5 tablets in 3 sets, for example, the following prescription data. It is possible to easily determine whether or not to use it as a prescription drug contained in. Therefore, in the drug distribution support device 5, the control unit 51 manages the remaining amount of the drug in the remaining drug information of each drug of the resident in the state at the time of dispensing, and the same applies to the dispensing support device 1. The above-mentioned residual drug information is transmitted.

[Alarm function]
By the way, it is conceivable that the control unit 51 has an alarm function for automatically setting an alarm based on the drug distribution data stored in the drug distribution data storage unit 523. Here, FIGS. 34 to 35 are diagrams showing an example of a medication schedule screen displayed when the drug distribution data is input.

Here, when the drug packaging device 3 executes the package-specific packaging process for each user, and the drug to be taken by one user is packaged in a series of the drug packages 81 at each time of administration, the first of these is Alternatively, a case where the drug inspection code is printed on the last drug package 81 by a one-dimensional code or a two-dimensional code will be described. Here, FIG. 36 is a diagram showing an example of a series of the drug packages 81 in which the drug inspection code is printed on the first drug package 81. In the example shown in FIG. 36, a two-dimensional code is printed as the drug inspection code on the first drug package 81, and the code indicating the first drug distribution information is printed on the second and subsequent drug packages 81. A one-dimensional code is printed as 811. In the drug test code, along with predetermined information necessary for the drug test of the drug package 81, drug distribution data such as a resident ID, a resident name, a dosing start date, a dosing end date, and a dosing time code are included. included. The dosing time code is a number or a symbol indicating the dosing time (before breakfast, after breakfast, before lunch, etc.) that needs to be taken between the dosing start date and the dosing end date. That is, here, by reading the drug inspection code of the first or last drug package 81 of the series of drug packages 81 corresponding to each resident, the drug distribution data corresponding to each resident is sequentially described. It shall be input to the drug distribution management device 5. The series of the drug packages 81 are delivered from the pharmacy A side to the LTCF B side as they are, or the LTCF 81 is individually separated from the Pharmacy A side to the LTCF. It will be delivered to the B side.

Then, in the drug distribution management device 5, when the drug distribution data is read from the drug inspection code of the drug package 81, the control unit 51 puts the drug package 81 into the drug package 81 based on the drug distribution data. The medication schedule of the corresponding resident is registered in the data storage unit 52. Here, the control unit 51 may display the dosing schedule screen 222 for confirming that the drug distribution data has been read on the reading terminal 7 or the display device 54 that has read the drug distribution data. Conceivable. Further, the dosing schedule screen 222 can be displayed on the mobile terminal 6 and the reading terminal 7 even when a predetermined user operation for confirming the medication schedule is performed on the mobile terminal 6 and the reading terminal 7. Is displayed.

Here, FIG. 34 is a diagram showing an example of the dose schedule screen 222. As shown in FIG. 34, in the upper part of the dosing schedule screen 222, the resident ID, the resident name, and the start of taking the resident corresponding to the drug distribution data finally read from the medicine package 81 are displayed. The date, end date of administration, etc. are displayed. Further, on the dosing schedule screen 222, a list of the drug distribution data corresponding to one or a plurality of residents that has already been read and stored in the data storage unit 52 is displayed in the lower row. When the specific drug distribution data is selected on the dose schedule screen 222 and the detail key is operated, the dose detail screen 223 that displays the details of the dose schedule corresponding to the drug distribution data is displayed. .. When the specific drug distribution data is selected and the delete key is operated, the control unit 51 can delete the medication schedule corresponding to the drug distribution data. Further, the information displayed in the upper part of the dosing schedule screen 222 may be switched to the information corresponding to the selected medicine distribution data according to the selection of the medicine distribution data in the lower part of the dosing schedule screen 222. ..

Here, FIG. 35 is a diagram showing an example of the dosage detail screen 223. As shown in FIG. 35, on the dosing detail screen 223, the resident ID, the resident name, the dosing start date, the dosing end date, etc. of the resident corresponding to the read drug distribution data are displayed in the upper part. Is displayed. Further, on the administration details screen 223, the scheduled administration date and the administration time from the administration start date to the administration end date corresponding to the drug distribution data corresponding to one resident are displayed in the lower part.

Then, when the drug distribution data is input, the control unit 51 automatically sets the alarm conditions for each of the resident's dosing times corresponding to the drug distribution data based on the drug distribution data. Set the alarm time to Execute the alarm setting process. Here, the control unit 51 when executing the relevant process is an example of the alarm setting means. Specifically, as the alarm conditions, the alarm time corresponding to the dosing time "after lunch" is "13:00", the alarm time corresponding to the taking time "between lunch" is "15:00", and the taking time "before dinner". It is conceivable that the corresponding alarm time is "18:00". In addition, as the alarm conditions, the alarm time corresponding to the dosing time "after lunch" is "12:30", the alarm time corresponding to the taking time "between lunch" is "15:00", and the dosing time "before dinner". It is conceivable that the corresponding alarm time is "18:30".

After that, the control unit 51, when the completion of administration corresponding to the administration time is not input at the alarm time of each of the administration times set by the alarm setting process, a message prompting the patient to take the administration time or the like. Is executed on the mobile terminal 6, the reading terminal 7, the display device 54 of the drug distribution support device 5, and the like. Here, the control unit 51 when executing the relevant process is an example of the alarm notification means. As a result, for each of the residents, omission of administration at each of the administration times is suppressed. The content of the alarm notification process is not limited to display, and may be, for example, voice notification. Further, when displaying the message or the like, the control unit 51 displays a list of patients for which the completion of administration has not been input, or displays a message or the like for each patient for which the completion of administration has not been input. Is possible.

Then, after the alarm notification process is executed at the alarm time, the control unit 51 determines that the administration of the administration time, which was the target of the notification, has not been taken, and the control unit 51 has not taken the administration of the administration time. Is recorded in the data storage unit 52. As a result, when the scheduled dose screen 222 is displayed, the control unit 51 displays a mark of "x" in the column corresponding to the time of taking the non-dose. For example, if the code information 811 corresponding to the dosing time is not read within a predetermined time set in advance after the alarm notification process is executed, the control unit 51 does not need to take the code information 811 at the dosing time. When an operation to that effect is performed, it is determined that the drug was not taken at the time of taking the drug. Further, when the control unit 51 moves the drug distribution targets in order while the list of patients for which the completion of administration has not been input is displayed, it corresponds to a patient different from the current drug distribution target patient. When the code information 811 is read, it may be determined that the current drug-distributed patient has not been taken. The control unit 51 moves the drug distribution targets in order while the list of patients is displayed, and when the code information 811 corresponding to the current drug distribution target patient is read, the patient's drug distribution target is read. Judging that the drug has been taken, the next patient is selected for drug distribution. Similarly, when the control unit 51 displays a message or the like in order for each patient for which the completion of administration has not been input, the code information 811 corresponding to a patient different from the patient corresponding to the currently displayed message or the like. If is read, it may be determined that the patient did not take the drug corresponding to the displayed message or the like. When the control unit 51 displays the messages and the like corresponding to each patient in order, the patient is taken when the code information 811 of the patient corresponding to the currently displayed message and the like is read. The message or the like corresponding to the next patient is displayed.

1: Dispensing support device 11: Control unit 12: Data storage unit 2: Reading terminal 3: Chemical packaging device 31: Control unit 32: Packaging printer 4: Printer 5: Dispensing support device 51: Control unit 52: Data storage Unit 6: Mobile terminal 61: Control unit 62: Camera 7: Reading terminal 81: Medicine package (an example of a packaging container)
82: Medicine bag (an example of a delivery container)
10: Drug distribution support system 100: Drug distribution support system

Claims (2)

A drug distribution data input method that can input drug distribution data including information on the timing of drug administration by multiple users, and
An alarm notification means that notifies a preset alarm time for each of the administration times, and an alarm notification means.
With the list of users who have not entered the completion of administration corresponding to the above-mentioned administration time displayed, select the recipients to be distributed in order, and select the recipient identification information corresponding to the current recipient of the medication. When the code containing the drug is read, it is determined that the current drug-distributed user has been taken, and the code containing the user identification information corresponding to the user different from the current drug-distributed user is When it is read, the control unit that determines that the current drug recipient has not been taken, and the control unit.
A drug distribution support system equipped with. A drug distribution data input method that can input drug distribution data including information on the timing of drug administration by multiple users, and
An alarm notification means that notifies a preset alarm time for each of the administration times, and an alarm notification means.
When the corresponding message is displayed in order for each user who has not entered the completion of administration corresponding to the time of administration, and the code including the user identification information of the user corresponding to the currently displayed message is read, the above-mentioned When it is determined that the user corresponding to the currently displayed message has been taken, and a code containing the user identification information of the user different from the user corresponding to the currently displayed message is read, the above-mentioned A control unit that determines that the user has taken the drug corresponding to the currently displayed message,
A drug distribution support system equipped with.

Images